data_2ksd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 120.46 0.172 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.45 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.418 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.456 0.17 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.546 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.431 0.158 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . . . . . . 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 28' ' ' ALA . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.63 0.253 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.454 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.492 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.557 0.218 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.501 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 79' ' ' GLN . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 76' ' ' VAL . 2.8 pt20 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 42' ' ' VAL . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.451 ' HG3' ' CG1' ' A' ' 75' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.568 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.755 0.312 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.568 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' CB ' HD22 ' A' ' 31' ' ' LEU . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.596 0.236 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' HD11 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.457 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.575 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.575 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 79' ' ' GLN . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.388 0.137 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.672 0.273 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.466 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.662 0.268 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 65' ' ' ILE . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 79' ' ' GLN . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HG3' HG11 ' A' ' 75' ' ' VAL . 28.8 mt-30 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.413 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.506 HD12 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.48 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 31' ' ' LEU . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.47 0.176 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -49.39 122.77 6.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.324 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -150.08 169.63 20.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.914 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 1.0 OUTLIER -137.75 -78.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.54 -26.91 4.61 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.206 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' O ' ' HE2' ' A' ' 17' ' ' LYS . 0.5 OUTLIER -70.82 60.72 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.152 0.501 . . . . 0.0 111.824 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.6 p -128.89 -51.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.7 mmt85 -151.46 102.51 2.9 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.951 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 32.0 65.32 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.927 0.491 . . . . 0.0 112.277 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.05 -155.02 0.55 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.463 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.5 OUTLIER 74.51 72.25 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.19 0.519 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.7 -48.71 16.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.966 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -39.7 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.584 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.75 -43.88 13.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.428 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.12 70.48 4.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.9 67.15 0.06 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.927 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.84 101.38 1.62 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.24 110.8 6.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.731 0.301 . . . . 0.0 111.699 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -141.93 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -157.56 -64.02 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -175.7 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 53' ' ' ILE . 1.3 tt 40.31 50.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.85 55.4 9.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.44 -28.7 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.918 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 7.2 tp 42.0 71.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.477 0.655 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 82.25 141.03 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.385 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -57.7 -56.82 17.0 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.635 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.45 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.427 ' HG3' ' CB ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -45.66 105.13 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.547 ' HA ' HD21 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -69.84 64.05 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 47.9 mt-10 -101.5 142.4 32.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.621 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 63.0 -67.55 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' GLU . 8.4 t -122.72 116.75 24.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.795 0.331 . . . . 0.0 111.098 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.427 ' HA ' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -50.3 121.98 6.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.894 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.438 ' HB2' HD23 ' A' ' 18' ' ' LEU . 2.6 tp-100 -137.35 -73.99 0.42 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.195 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 58.01 81.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.801 0.334 . . . . 0.0 111.464 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 tp -127.77 62.36 1.4 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 112.031 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.427 ' CB ' ' HG3' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -140.44 147.27 39.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.302 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.231 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.402 0.144 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.462 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -146.12 153.3 40.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.774 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 22.6 ttmt -173.41 111.9 0.2 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -140.56 -66.45 0.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -59.96 85.55 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.977 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER 38.97 59.89 1.54 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.757 0.423 . . . . 0.0 111.769 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 38.8 t 88.12 -19.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.732 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 53.0 mtm-85 -85.37 169.34 13.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.151 0.5 . . . . 0.0 111.843 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 16' ' ' MET . 5.1 m-85 -74.97 130.67 39.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t 65.88 177.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 63.49 8.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.147 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.26 -39.92 23.03 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.668 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -47.75 -38.41 15.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.644 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.89 -39.03 11.39 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 87' ' ' LEU . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.85 63.87 7.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 0.6 OUTLIER -101.42 131.61 47.43 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.885 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.78 -144.15 3.85 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.585 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -72.55 95.62 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.666 0.27 . . . . 0.0 110.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.74 179.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.73 -49.26 3.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.3 m -53.28 -62.0 1.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.578 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 tt -175.5 -57.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.566 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -134.47 -62.39 0.74 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.442 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.66 141.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 112.129 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.97 -67.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.237 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -80.28 64.66 5.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p -65.78 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.418 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -57.38 -64.8 0.77 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 35.69 38.02 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.96 -76.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.046 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.87 163.7 13.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.561 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -158.43 58.81 0.45 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.739 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -82.29 -27.99 32.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.342 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -53.0 19.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 -67.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.197 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.3 OUTLIER -166.3 -56.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -100.89 150.74 22.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.065 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.502 0.191 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 152.63 45.36 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.25 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -99.71 -59.18 1.77 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 27' ' ' LEU . 1.4 tt -76.72 -57.21 3.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.476 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.27 61.92 2.88 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.941 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 58.68 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 111.841 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.22 -58.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.026 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -83.59 -32.63 25.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.658 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.23 154.58 46.93 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 26' ' ' LEU . 4.3 t -166.82 -173.08 2.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' HA ' ' OE1' ' A' ' 79' ' ' GLN . 0.7 OUTLIER 63.39 -65.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.5 mm? -65.0 -40.87 95.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.983 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HB3' ' HG ' ' A' ' 18' ' ' LEU . 3.9 mt -47.69 -33.55 7.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -32.93 14.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.326 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 75.36 0.38 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 154.17 43.7 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.42 -65.7 0.02 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.053 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -72.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.649 0.262 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.57 127.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.817 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.72 173.71 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t 59.66 -157.99 0.32 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.932 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.6 mt -143.55 122.56 7.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 110.917 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -62.07 154.14 27.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.792 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t 67.09 -65.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.888 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 59' ' ' ILE . 12.5 pt -73.24 62.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -67.07 -47.75 70.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.017 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p -68.51 -57.83 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 56' ' ' ILE . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.546 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -71.64 81.56 0.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.68 112.03 0.15 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.87 -68.4 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.434 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 52.64 41.24 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.074 0.464 . . . . 0.0 111.144 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.8 t -127.11 -156.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.356 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 55.74 0.7 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 -173.96 2.42 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -70.79 55.48 0.17 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 111.576 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 14.5 tp 172.16 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.07 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -77.53 172.97 12.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.862 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.356 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.381 0.134 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -140.43 -51.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.717 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.0 mtpt 74.66 -165.29 0.09 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.837 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 4.9 mp 71.43 -64.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.546 0.338 . . . . 0.0 111.593 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.13 94.52 0.07 OUTLIER Glycine 0 C--N 1.335 0.52 0 O-C-N 123.418 0.448 . . . . 0.0 113.467 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.4 83.08 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.02 -74.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.62 -51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.99 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -115.1 36.78 3.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.617 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.6 p -127.27 -83.49 0.61 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.85 60.37 5.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -42.85 90.0 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 mt -47.51 -31.4 4.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.529 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.1 -44.33 15.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.09 58.76 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 149.51 35.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.65 -61.22 0.67 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.164 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.7 -55.99 1.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.42 68.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.06 -54.58 5.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.3 m 58.91 65.02 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.939 0.399 . . . . 0.0 111.708 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.64 -33.62 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.506 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -99.87 -74.63 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.286 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.96 60.48 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 110.915 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 56' ' ' ILE . 4.8 tt -76.51 122.89 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 111.675 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.637 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 8.0 mtp85 -78.24 68.39 4.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -53.19 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.97 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.592 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -71.61 -52.7 16.69 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.31 -67.96 0.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.038 0.535 . . . . 0.0 111.652 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 18' ' ' LEU . 6.1 mt-10 -133.55 -47.33 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.003 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.92 -62.3 0.32 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.69 -62.61 0.45 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.586 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.9 62.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.755 0.312 . . . . 0.0 111.643 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER 46.3 66.2 1.01 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.722 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 7.3 mpt_? 73.56 130.52 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -77.95 -38.8 44.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.192 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.9 t -117.89 -167.97 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.242 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.621 -0.705 . . . . 0.0 111.28 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.2 158.59 22.05 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.731 0.301 . . . . 0.0 111.44 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.34 97.8 1.0 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.87 68.5 9.99 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.609 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.34 65.25 0.25 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.292 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pp -157.64 -41.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.432 0.293 . . . . 0.0 111.413 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.4 m -56.75 141.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -71.7 62.35 0.4 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.217 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.26 55.3 0.74 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 110.968 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.75 133.29 8.31 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 69.98 -60.85 0.47 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.284 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.0 mt -47.12 -49.5 21.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.672 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -51.51 -41.69 61.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -56.13 -32.36 64.17 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 28' ' ' ALA . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.84 134.92 43.38 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -59.97 0.5 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 -39.11 2.85 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.905 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.92 32.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 111.714 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.4 p -89.28 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.269 0.557 . . . . 0.0 111.191 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -49.6 -37.7 28.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.554 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -104.75 99.5 9.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.693 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.92 -45.72 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 111.165 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.5 -67.27 0.95 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.2 t -141.27 132.05 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.805 0.335 . . . . 0.0 110.955 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.88 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 112.104 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER 62.63 87.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.501 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.37 -59.29 2.48 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.266 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.454 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 87' ' ' LEU . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 17.5 tt0 -68.69 -19.42 64.38 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER 66.18 97.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -116.12 -60.49 1.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.724 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -81.33 -79.3 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -79.65 178.23 8.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.21 0.528 . . . . 0.0 111.925 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -98.71 63.17 1.41 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.882 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -66.87 -44.2 81.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.827 0.346 . . . . 0.0 110.068 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 69.29 84.28 0.15 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.684 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -124.29 -77.16 0.59 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.279 178.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 54.6 p -109.95 -81.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.959 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.577 0.751 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.522 0.201 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 2.4 mpp? -74.35 86.08 1.98 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 16' ' ' MET . 57.2 mttt 81.42 130.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.015 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 3.7 mm? -72.67 -51.44 19.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.26 -90.52 0.83 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.236 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 tp -103.93 -63.13 1.22 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.758 0.314 . . . . 0.0 111.081 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 17' ' ' LYS . 3.4 t 67.85 40.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.941 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -95.18 -42.42 8.58 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.468 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.73 78.6 1.64 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.658 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p 71.0 -176.82 0.2 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.793 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.1 tpt -76.22 64.71 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.44 -46.16 56.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.497 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 HD11 ' HG2' ' A' ' 81' ' ' GLU . 2.8 mm? -46.9 -34.11 5.16 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.82 11.73 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 82' ' ' GLU . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 84.48 1.18 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -39.2 116.32 0.58 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.406 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.5 -66.18 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.49 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.62 143.17 50.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.559 0.219 . . . . 0.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -52.0 -48.51 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.922 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.15 101.1 0.53 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.238 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.31 169.23 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mt -88.52 1.9 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.757 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.05 169.3 10.04 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.16 -47.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.053 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.512 HG22 ' HG2' ' A' ' 57' ' ' ARG . 3.1 tt -160.31 -45.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.672 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.68 57.37 1.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.045 0.45 . . . . 0.0 110.9 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t -65.3 -50.67 64.8 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.14 164.93 12.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -65.08 1.22 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.586 0.231 . . . . 0.0 111.36 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -132.89 139.11 47.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.138 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' HA ' ' CB ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 55.59 -164.21 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 10.1 t -121.15 -40.73 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -70.04 94.46 0.87 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.452 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 0.6 OUTLIER 75.45 115.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.23 92.6 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.327 0.584 . . . . 0.0 111.777 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.46 162.9 40.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.874 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t 69.66 172.32 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 111.446 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.335 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 82' ' ' GLU . 10.8 tmm? . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.02 -58.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.546 0.338 . . . . 0.0 111.718 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -123.55 75.13 1.3 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.95 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 6.9 tt -138.59 129.21 26.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.32 105.7 0.86 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.242 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.89 -41.63 46.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.809 0.338 . . . . 0.0 110.77 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -120.48 83.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.7 ttt180 91.84 154.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.983 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -52.31 144.11 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.87 157.99 0.17 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.032 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 44.6 ttm -74.21 74.58 1.8 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.463 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mp -50.3 -36.17 30.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tp -49.46 -33.98 15.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 -35.93 2.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.433 HG23 ' HA ' ' A' ' 50' ' ' VAL . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 127.66 32.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -56.24 -35.52 67.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.3 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.05 124.11 6.4 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.041 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.73 105.99 0.51 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 111.584 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 43' ' ' THR . 21.4 t 78.56 129.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.689 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 59.2 0.86 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.214 0.53 . . . . 0.0 110.791 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.6 p -177.95 43.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.95 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 pt -75.13 -31.09 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.69 -57.19 6.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.4 86.99 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 tt -81.64 97.07 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.324 0.583 . . . . 0.0 111.049 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 2.7 mmm-85 -135.0 128.71 32.91 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.325 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -56.76 -60.23 3.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.879 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.505 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.615 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.528 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.38 107.6 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.71 90.42 2.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -62.22 -179.11 0.2 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.221 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 18' ' ' LEU . 22.3 mt-10 68.27 -57.74 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.198 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.5 p -51.68 135.76 28.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.835 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -72.54 63.57 0.58 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 110.837 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 1.8 tt0 75.15 136.13 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -98.44 -39.0 8.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.758 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.51 -53.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -157.79 -166.37 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.456 ' CG ' HD13 ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.389 0.138 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.22 153.71 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.993 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.54 57.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.385 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mp -94.38 123.26 37.68 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.891 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.07 66.48 0.5 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.257 -0.496 . . . . 0.0 113.336 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.08 -65.32 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.521 0.201 . . . . 0.0 111.193 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 22' ' ' ARG . 40.7 t -130.68 -72.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' HG2' HG12 ' A' ' 21' ' ' VAL . 25.2 ptt180 -175.91 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.35 40.69 1.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.71 175.32 6.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.644 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.14 63.25 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.408 0.623 . . . . 0.0 111.991 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.1 -34.43 78.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.292 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tp -47.46 -36.9 10.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.91 10.2 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 HD13 ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.658 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -52.22 63.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -163.39 67.59 0.19 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.016 0.436 . . . . 0.0 110.646 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.658 ' HA3' ' HA ' ' A' ' 44' ' ' MET . . . -82.38 -107.49 0.43 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.375 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 6.8 mt-30 54.56 66.01 1.35 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.414 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 59.4 t 85.11 -41.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.196 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER 66.05 -63.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.5 p -168.63 120.81 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.657 0.265 . . . . 0.0 111.203 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.6 pp -56.72 -35.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.097 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -127.04 177.29 6.74 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.013 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 58' ' ' SER . 13.0 p -71.15 58.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.532 0.682 . . . . 0.0 111.408 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.446 HG21 ' HG3' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -60.37 -35.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.486 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 66.0 mtt-85 -97.44 31.32 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . 39.0 t -53.19 -62.86 1.38 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.255 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 79' ' ' GLN . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.595 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 2.8 pt20 -92.64 -170.89 2.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.73 174.56 8.33 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -69.43 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.518 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -150.44 -49.82 0.13 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 m -75.85 -69.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.094 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.16 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.975 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -152.32 34.15 0.52 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.429 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.595 ' HD2' ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -175.17 159.37 2.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.23 128.13 54.45 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.845 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 p -148.2 172.35 14.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.326 0.108 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.45 150.0 49.72 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.122 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -74.48 66.08 1.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.107 0.479 . . . . 0.0 111.643 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mp -78.65 61.68 3.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -71.5 0.89 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.55 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 24' ' ' SER . 0.2 OUTLIER -81.29 141.37 34.14 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.636 0.255 . . . . 0.0 110.892 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.64 -32.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.537 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -107.58 173.1 6.47 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.339 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.81 61.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.117 0.484 . . . . 0.0 111.738 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.404 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . 28.3 t -100.63 -160.89 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.794 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.517 ' CE ' ' HB3' ' A' ' 79' ' ' GLN . 4.5 tpt 54.06 42.4 31.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.851 0.357 . . . . 0.0 111.307 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 pp -44.37 -37.27 3.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.072 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.99 -35.63 11.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.77 -41.76 15.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.457 HG22 ' HG3' ' A' ' 51' ' ' GLU . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 42' ' ' VAL . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -84.74 -176.4 6.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -50.18 -45.97 53.88 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.41 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.27 -99.58 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.041 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.73 -57.35 0.51 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 111.537 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.582 ' HB ' HG12 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -150.07 117.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.763 0.316 . . . . 0.0 111.292 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' A' ' 43' ' ' THR . 18.0 mp0 -69.91 58.53 0.15 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.458 ' OG ' HG12 ' A' ' 56' ' ' ILE . 1.2 m 59.48 84.71 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.578 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG12 ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -102.65 -75.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.1 -45.15 3.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -37.37 -46.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.458 HG12 ' OG ' ' A' ' 52' ' ' SER . 1.5 pp -94.48 134.03 33.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 111.146 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -71.58 92.89 1.17 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.62 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p -31.75 -55.54 0.28 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.096 0.558 . . . . 0.0 112.46 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.422 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.451 ' CG1' ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' HB3' ' CE ' ' A' ' 25' ' ' MET . 0.4 OUTLIER -112.57 121.51 45.0 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pp -65.99 133.01 49.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' HG3' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -116.39 169.27 9.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.69 52.07 1.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.987 0.423 . . . . 0.0 111.401 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' OG ' ' NH1' ' A' ' 84' ' ' ARG . 4.5 t -133.12 -59.09 0.89 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' NH1' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -165.54 29.11 0.05 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.0 -179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.57 170.52 0.26 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.099 0.476 . . . . 0.0 111.136 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.9 mmm180 -131.24 -103.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.61 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mt -90.89 89.37 7.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.769 0.319 . . . . 0.0 110.681 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.84 -50.16 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.655 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.4 tpt85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.385 179.692 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.47 0.176 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.21 175.7 5.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 138.75 52.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -164.77 162.9 21.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.03 -139.37 2.5 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.2 tp -71.33 70.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.299 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.11 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.333 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -107.15 -54.69 2.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.91 131.37 42.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 t 73.06 160.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.536 . . . . 0.0 112.029 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.8 mtt -82.93 69.2 9.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -42.12 98.15 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.682 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.36 -39.15 2.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.03 17.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.909 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -58.59 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 53.36 46.41 26.38 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.25 -167.39 12.47 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.501 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.75 -67.93 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.606 0.362 . . . . 0.0 111.665 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.1 t -136.45 100.67 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.28 -69.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.4 p -137.13 79.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.674 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.23 178.51 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.98 -172.6 0.19 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -80.06 66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 tp -101.2 -40.05 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.106 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 59.43 79.84 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.75 0.31 . . . . 0.0 111.5 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t -28.39 -49.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.44 70.38 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.44 -58.58 7.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 2.2 tt0 -158.58 88.44 0.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.4 tt0 76.91 159.6 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.054 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER 73.69 144.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 65.5 54.78 1.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.345 0.593 . . . . 0.0 110.277 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -82.67 -35.85 26.47 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.422 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -97.03 -54.78 3.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.32 -69.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -37.51 10.44 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.283 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.313 0.101 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 69.08 -64.2 0.34 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -112.25 -64.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 69.81 -178.12 0.22 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.872 0.368 . . . . 0.0 111.258 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 25' ' ' MET . . . -174.06 59.98 0.13 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.631 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 26' ' ' LEU . 0.2 OUTLIER 83.21 145.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.155 0.582 . . . . 0.0 111.641 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -78.95 62.68 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.377 0.608 . . . . 0.0 111.477 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.21 58.88 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 111.031 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 71.88 -64.39 0.39 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.546 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -131.94 -163.58 1.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.625 0.25 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 19' ' ' GLY . 21.1 ttt -66.73 95.07 0.33 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.629 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' HD12 ' A' ' 20' ' ' LEU . 5.0 tp -49.27 -46.54 46.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.278 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.54 -38.25 66.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.76 54.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.713 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.568 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' CG2' ' HA ' ' A' ' 51' ' ' GLU . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.53 77.67 7.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.6 t60 77.22 -55.57 0.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.38 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . 127.49 -135.52 8.79 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.111 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mp0 68.42 -179.54 0.23 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.666 0.27 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.489 HG23 ' HG3' ' A' ' 51' ' ' GLU . 15.5 m -68.82 -43.59 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' HA ' ' CG2' ' A' ' 43' ' ' THR . 0.0 OUTLIER -166.36 -52.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.432 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.5 p -120.09 155.69 32.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.337 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.07 -44.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -169.08 -68.02 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.154 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 m -68.84 62.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.165 0.507 . . . . 0.0 111.49 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.5 tp -122.42 142.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.235 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 mtp180 -125.88 102.87 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t -44.49 -48.99 10.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.568 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' CB ' HD22 ' A' ' 31' ' ' LEU . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -55.49 -56.86 15.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.8 -158.7 0.25 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.13 53.8 1.28 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.177 0.513 . . . . 0.0 110.657 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.38 -58.73 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.32 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -44.65 114.88 0.77 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.142 0.496 . . . . 0.0 111.93 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -84.36 61.49 6.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.79 30.63 6.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.317 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -105.23 135.82 45.88 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.88 -45.89 11.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.991 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 m -169.22 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.032 -0.985 . . . . 0.0 111.613 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.386 0.136 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.456 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -122.32 162.18 21.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 16' ' ' MET . 40.7 mttm 73.48 154.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.704 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -146.05 178.94 7.83 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 67.62 1.14 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.8 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 70.33 173.83 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 HG21 ' HG2' ' A' ' 22' ' ' ARG . 30.0 m -93.93 -39.71 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HG2' HG21 ' A' ' 21' ' ' VAL . 39.5 ptt85 -142.15 -48.38 0.36 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.93 -24.04 56.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.8 t 68.87 -162.74 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.713 0.292 . . . . 0.0 111.292 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.527 ' HE1' HG11 ' A' ' 76' ' ' VAL . 55.6 mtm -109.01 111.64 23.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -52.34 -42.97 64.34 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.987 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.53 -44.73 46.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.64 -34.17 36.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.555 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.457 ' HA ' ' C ' ' A' ' 48' ' ' GLY . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.49 -50.44 63.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.0 -59.06 0.8 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.709 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' C ' ' HA ' ' A' ' 44' ' ' MET . . . 170.92 173.62 38.17 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.971 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.04 69.05 1.91 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.95 127.82 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.578 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 52' ' ' SER . 8.4 mm-40 -79.04 80.01 5.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 63.6 m 74.98 168.21 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.074 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 tt -128.89 118.53 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 47.32 48.42 16.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 p -160.25 101.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.044 0.45 . . . . 0.0 111.491 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.2 tt -77.12 65.69 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.494 0.664 . . . . 0.0 111.415 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -85.12 62.08 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.344 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -69.51 -69.02 0.37 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.762 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' HA ' HD11 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA2' ' CD1' ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD11 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.457 ' CD1' ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.575 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.575 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 79' ' ' GLN . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HE1' ' A' ' 25' ' ' MET . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.29 64.06 0.25 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -44.5 6.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.352 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.52 112.97 23.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.809 0.338 . . . . 0.0 111.745 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.44 139.64 52.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.001 0.429 . . . . 0.0 111.163 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -172.16 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.78 -56.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.197 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 58.95 -171.66 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.959 0.409 . . . . 0.0 111.594 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.2 173.89 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -101.06 -50.67 3.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.943 -179.671 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.4 mtp -148.79 -81.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.134 0.271 . . . . 0.0 111.026 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tttp 75.04 120.02 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.16 -164.08 0.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.987 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.514 ' HA2' ' CB ' ' A' ' 28' ' ' ALA . . . -75.06 110.93 3.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 24' ' ' SER . 6.3 tt 75.95 -63.25 0.4 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.573 0.349 . . . . 0.0 110.936 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.0 p -171.61 -43.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 66.15 0.92 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 111.507 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 t80 67.27 69.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.698 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 1.8 m -134.34 -56.57 0.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.2 mtt -88.29 116.61 26.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 110.75 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -58.37 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' CD2' ' HB3' ' A' ' 79' ' ' GLN . 1.6 mp -38.72 -41.64 0.73 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' CB ' ' HA2' ' A' ' 19' ' ' GLY . . . -45.8 -42.43 12.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 157.93 9.65 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.63 -31.61 70.8 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.64 -173.78 37.44 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.01 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.81 117.58 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.305 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.26 -70.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.574 ' HB3' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -111.28 120.88 43.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.083 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.594 ' HA ' ' HB ' ' A' ' 56' ' ' ILE . 4.4 m -167.57 45.97 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.934 0.397 . . . . 0.0 111.399 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 tt -162.29 -47.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.73 -70.72 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.7 0.285 . . . . 0.0 111.532 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.25 22.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.76 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.594 ' HB ' ' HA ' ' A' ' 52' ' ' SER . 24.8 mm -103.84 80.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.013 0.435 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.56 35.47 22.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.14 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 p -59.19 -64.33 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.095 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.594 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.438 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 27' ' ' LEU . 65.2 mt-30 -58.27 -75.87 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 34.26 34.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' C ' HD11 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -139.3 98.02 3.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 110.927 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.21 69.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.678 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -78.27 -175.43 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.844 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -53.63 8.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.465 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.8 OUTLIER -174.73 155.41 2.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.986 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 33.26 74.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.588 0.555 . . . . 0.0 112.108 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 ' CD2' ' HB3' ' A' ' 81' ' ' GLU . 44.2 tp -81.95 -56.65 3.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t -76.68 153.29 35.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.098 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.216 0.055 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.3 ttm 72.27 166.6 0.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.246 0.342 . . . . 0.0 111.285 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.51 35.51 4.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.24 106.06 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.33 -81.3 0.2 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.577 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -96.27 -75.91 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.65 -53.83 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.81 -57.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.11 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.5 90.17 3.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.288 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m -154.08 169.26 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.57 45.23 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tp -42.81 -38.97 2.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.818 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mp -44.34 -39.15 4.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.446 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.42 -48.38 26.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 53' ' ' ILE . 3.5 tt -84.69 78.3 9.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 78.66 0.12 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.36 -22.4 58.62 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.681 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt-30 -79.17 150.84 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.058 0.429 . . . . 0.0 110.834 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 37.2 t 78.97 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -45.23 -40.38 7.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -144.45 46.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 46' ' ' LEU . 3.4 mp 69.0 -58.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.436 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.83 -171.33 3.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.877 0.37 . . . . 0.0 111.361 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 m -70.49 69.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -86.47 150.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.261 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' CB ' ' HB2' ' A' ' 60' ' ' PHE . 1.5 mpp_? -90.08 128.74 36.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p -60.64 -65.18 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.608 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.519 ' HB2' ' CB ' ' A' ' 57' ' ' ARG . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 89' ' ' ARG . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -80.69 66.87 6.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 tt -72.22 72.93 0.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.522 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.18 -60.0 0.5 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.479 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -61.65 0.46 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.529 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 14.8 t -176.52 -178.85 0.96 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 111.822 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -77.49 75.91 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.29 59.14 0.83 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.247 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 0.3 OUTLIER -88.43 -59.88 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.722 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 pp -140.87 159.05 43.04 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.498 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -175.85 5.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HB3' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.16 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.569 0.223 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.8 mmt -75.76 165.45 25.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.166 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 133.02 35.42 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.281 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.8 -53.06 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.47 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.5 104.35 1.5 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tt -41.5 -56.46 2.53 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.0 106.93 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.894 0.378 . . . . 0.0 111.661 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 49.25 40.75 18.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.291 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 98.9 m-85 59.77 35.6 22.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 31.4 t -46.89 -64.39 0.79 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.1 ttm -59.84 -51.42 69.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.877 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 5.4 tt -49.08 -40.61 32.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.058 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -44.7 -35.6 2.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.298 179.429 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.75 -37.94 31.67 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -75.21 -179.25 4.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.73 63.4 1.15 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.51 -64.31 2.52 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 71.89 171.42 0.31 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.503 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.12 72.63 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.622 0.725 . . . . 0.0 110.934 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' HB2' HG13 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -123.35 -47.95 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.768 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . 10.3 m -50.33 153.96 1.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.731 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.28 -49.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -87.36 -49.83 6.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 110.241 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG13 ' HB2' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -78.24 169.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.761 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.11 65.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.109 0.481 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -107.04 -26.18 11.27 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -50.57 -57.5 8.01 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.466 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 81' ' ' GLU . 29.2 tt0 -58.09 109.89 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.9 67.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.119 0.485 . . . . 0.0 111.224 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -166.42 -179.8 5.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.588 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -73.58 -79.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.839 -0.164 . . . . 0.0 110.609 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t 62.41 -62.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.797 0.332 . . . . 0.0 111.467 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -138.04 64.26 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 1.2 mp0 74.22 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.299 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 84.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.302 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.89 84.48 2.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.446 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -108.81 117.14 33.42 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.28 153.07 39.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.943 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 80' ' ' LEU . 4.4 pttt -164.62 86.64 0.45 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.33 165.75 30.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 25' ' ' MET . . . -114.18 -52.45 0.45 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.833 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 -58.45 2.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.455 0.169 . . . . 0.0 111.264 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.88 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -142.33 51.81 1.46 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 24' ' ' SER . 6.2 p90 -161.27 52.84 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.642 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 52.0 m 71.58 175.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.446 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.467 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 2.0 mpp? -96.11 66.08 2.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD2' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.81 -26.05 63.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.8 -37.78 14.36 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.1 26.79 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 88' ' ' SER . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 HD13 ' A' ' 87' ' ' LEU . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 117.51 4.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.48 70.32 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.149 0.499 . . . . 0.0 111.004 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 148.54 123.87 1.35 Allowed Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.172 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.12 152.11 44.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.401 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.9 m -68.63 64.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.995 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.31 30.92 13.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.637 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.2 p -154.01 99.7 2.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.452 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tp -121.05 -53.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -112.31 29.62 7.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.695 0.283 . . . . 0.0 111.589 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.13 133.04 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.77 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 56' ' ' ILE . 50.4 mm -73.08 -50.55 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER 50.94 48.52 22.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.636 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t -44.77 -51.79 9.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.316 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 65' ' ' ILE . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.437 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 79' ' ' GLN . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 80' ' ' LEU . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HG3' HG11 ' A' ' 75' ' ' VAL . 28.8 mt-30 -61.5 -39.15 89.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.46 HD11 ' HA ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -52.47 -44.73 65.76 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.321 178.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -79.71 -41.93 25.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.758 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.6 -165.14 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.634 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 45.54 50.92 10.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -116.16 -64.67 1.28 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.21 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -157.36 -79.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 179.65 140.67 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.028 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.13 -41.43 2.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.757 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 20.8 t -174.02 -50.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.162 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 O-C-N 123.849 0.718 . . . . 0.0 111.695 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.312 0.101 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.39 137.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.301 0.376 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 77' ' ' VAL . 4.7 mtmt 55.94 79.11 0.17 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.943 0.401 . . . . 0.0 111.6 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.34 -59.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.038 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.18 -173.55 22.93 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 24.21 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.807 0.337 . . . . 0.0 111.694 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.23 87.9 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 111.1 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.94 -149.33 0.44 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.24 -38.91 6.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -73.86 -13.24 60.89 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.5 mmt 54.45 51.33 14.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -39.72 -39.26 0.75 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.471 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 4.0 mp -42.81 -39.47 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.46 -34.53 7.43 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.816 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.506 HD12 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.505 ' HA ' ' CG2' ' A' ' 50' ' ' VAL . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.46 160.5 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -128.74 88.71 2.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.668 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.46 79.98 1.24 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.369 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.79 -75.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.139 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 43' ' ' THR . 6.4 m -77.39 62.72 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.881 0.372 . . . . 0.0 111.637 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 43' ' ' THR . 0.0 OUTLIER -157.07 179.22 9.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.3 72.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.218 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.85 -51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.376 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.59 -42.07 59.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 111.065 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.22 85.45 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.213 0.53 . . . . 0.0 110.49 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.19 128.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.642 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 2.7 ttt180 71.99 109.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.835 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p -49.3 -52.73 25.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.48 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.535 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.535 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' CZ ' ' HD3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.506 ' CG1' HD12 ' A' ' 31' ' ' LEU . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 17' ' ' LYS . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 126.43 24.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.48 -162.82 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.66 61.76 0.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.08 0.466 . . . . 0.0 111.591 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -112.71 -71.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.204 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.566 ' HB2' ' HG ' ' A' ' 27' ' ' LEU . 7.1 t 66.82 -161.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.481 ' NH1' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 58.82 61.92 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.684 -179.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.481 ' HB2' ' NH1' ' A' ' 84' ' ' ARG . 1.9 tt0 65.44 -161.8 0.26 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.662 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.24 174.9 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.59 0.233 . . . . 0.0 111.342 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER 33.95 65.85 0.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.191 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 1.4 t -146.25 94.0 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.378 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 17.6 tpp85 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.612 -0.708 . . . . 0.0 111.103 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -130.56 171.92 12.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.68 124.47 42.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.58 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.39 -72.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.82 129.39 2.4 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.688 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER 52.95 -173.48 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG22 ' HG ' ' A' ' 20' ' ' LEU . 97.7 t 71.41 121.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.936 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.12 150.52 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -49.87 104.05 0.06 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -177.64 -61.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.516 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.95 115.53 13.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.434 179.448 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 pp -112.02 -34.16 6.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.837 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.91 -42.42 2.75 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . . . -39.8 -40.47 0.97 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' HB2' ' OE1' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tt -63.67 123.17 18.17 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.88 154.23 42.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.792 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 -55.89 4.79 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.589 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.83 68.31 0.87 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.693 0.282 . . . . 0.0 111.266 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 50' ' ' VAL . 7.6 p 41.16 71.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.615 0.721 . . . . 0.0 112.414 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -69.85 63.53 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.5 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.11 35.45 24.79 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.813 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 pp -94.96 -34.47 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -68.27 0.63 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.949 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 m -74.91 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.262 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -76.55 64.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.457 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -123.23 60.92 1.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.348 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t -52.98 -51.39 61.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.591 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -126.96 145.67 50.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.9 tp -97.91 -67.23 0.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.788 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.647 ' HB2' ' HA ' ' A' ' 87' ' ' LEU . 1.4 mp0 -102.72 69.14 1.06 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 110.598 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -58.3 133.26 55.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.726 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m 178.13 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.468 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.48 -42.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -142.24 -50.84 0.39 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.472 ' HA ' ' CD ' ' A' ' 79' ' ' GLN . 3.9 ptp180 -171.54 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 6.3 mp -115.43 156.87 24.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.619 0.247 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -54.71 98.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.381 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.422 0.153 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.93 172.17 13.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.832 0.349 . . . . 0.0 111.515 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.21 117.6 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.122 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.77 137.52 7.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.53 51.48 4.58 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.074 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tp 76.39 -156.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.543 0.337 . . . . 0.0 111.521 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.0 t -73.87 -70.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.6 mtm-85 -150.46 120.35 7.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.165 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 68.57 101.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.027 0.441 . . . . 0.0 111.398 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -169.88 -178.81 3.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.1 ttt 55.45 57.87 5.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.95 -40.09 6.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -40.72 -44.37 2.17 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.785 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . . . -47.09 -49.23 22.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' CD1' ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -58.7 7.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.69 109.29 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.043 0.449 . . . . 0.0 111.889 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.76 -90.68 0.08 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.053 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -137.8 -64.68 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.601 0.239 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -139.76 155.64 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.139 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 117.69 5.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.629 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.445 ' OG ' ' HA ' ' A' ' 56' ' ' ILE . 5.4 m -174.8 129.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 111.771 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 pp -97.2 -39.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.75 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -104.77 -71.02 0.75 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.791 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 p -121.14 142.69 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 3.8 pt -74.92 90.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 110.979 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -147.12 76.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.477 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t -61.87 -50.77 70.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.458 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.582 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.488 ' CE3' ' HA ' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.35 91.85 0.77 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tp -50.14 112.39 0.67 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.92 57.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.677 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.49 -78.69 0.14 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.265 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -97.66 142.48 29.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.415 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.95 -174.44 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.53 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.16 -169.19 2.98 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.43 117.21 3.13 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.973 0.415 . . . . 0.0 111.354 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.36 45.67 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.512 ' OG ' ' HD3' ' A' ' 89' ' ' ARG . 47.9 t -121.21 -54.0 2.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.512 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.814 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 111.501 0.185 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -119.01 177.1 4.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.625 0.25 . . . . 0.0 110.907 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -71.85 -65.98 0.7 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.41 46.9 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.45 44.85 7.71 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -71.84 142.35 49.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.244 0.545 . . . . 0.0 111.898 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 57.2 t -70.69 137.26 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.747 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 3.0 mmt180 70.18 79.07 0.19 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.752 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 78.9 m-85 75.6 96.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.278 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 42.4 t -142.9 148.72 37.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.544 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.614 ' SD ' ' HA ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER 59.41 49.8 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.019 0.438 . . . . 0.0 111.014 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.01 -40.42 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.65 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.471 ' CD1' ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -47.05 -30.96 2.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.183 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.66 -38.3 6.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.34 116.24 15.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 163.02 29.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.36 45.39 4.38 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.102 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -177.86 5.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 111.224 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.6 m -77.93 -157.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.74 100.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t 72.9 149.16 0.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.412 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.28 65.3 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.247 0.546 . . . . 0.0 110.886 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -170.08 -172.75 1.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.841 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ARG . 93.7 t -79.48 140.33 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.387 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.54 70.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.334 0.587 . . . . 0.0 111.142 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -175.36 90.41 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.573 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t -48.82 -51.01 31.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.527 HG11 ' HG2' ' A' ' 25' ' ' MET . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -42.8 67.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.614 ' HA ' ' SD ' ' A' ' 25' ' ' MET . 0.2 OUTLIER 50.17 -96.49 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.127 0.267 . . . . 0.0 110.997 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.471 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 2.5 mt-10 -171.57 40.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -86.02 64.45 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.446 ' O ' HD11 ' A' ' 27' ' ' LEU . 20.9 t 57.36 -153.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.673 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 113.82 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.189 -0.319 . . . . 0.0 110.95 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.48 111.89 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.47 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -75.81 -21.35 57.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.64 77.75 1.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.027 0.442 . . . . 0.0 111.209 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.4 p -58.8 -46.7 86.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.702 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 120.46 0.172 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 79' ' ' GLN . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' THR . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 72' ' ' PHE . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' CD ' HD11 ' A' ' 31' ' ' LEU . 9.3 mm100 . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' LEU . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' VAL . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' TYR . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.456 0.17 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 38' ' ' VAL . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 HD12 ' H ' ' A' ' 59' ' ' ILE . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 73' ' ' LEU . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 72' ' ' PHE . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.431 0.158 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 34' ' ' LEU . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' VAL . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 41' ' ' ALA . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.62 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA2' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' ILE . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' THR . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 73' ' ' LEU . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 38' ' ' VAL . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.63 0.253 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' HE3' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' HD13 ' A' ' 64' ' ' LEU . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 76' ' ' VAL . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 72' ' ' PHE . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 73' ' ' LEU . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 71' ' ' TYR . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 72' ' ' PHE . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 37' ' ' VAL . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 33' ' ' VAL . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 33' ' ' VAL . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.669 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 66' ' ' THR . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 73' ' ' LEU . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.492 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 33' ' ' VAL . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 38' ' ' VAL . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.557 0.218 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.5 HD13 ' HE3' ' A' ' 68' ' ' TRP . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.5 ' HE3' HD13 ' A' ' 65' ' ' ILE . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 71' ' ' TYR . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 76' ' ' VAL . 2.8 pt20 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 38' ' ' VAL . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.886 HG12 ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 72' ' ' PHE . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 73' ' ' LEU . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.886 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 33' ' ' VAL . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 34' ' ' LEU . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 76' ' ' VAL . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 72' ' ' PHE . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 38' ' ' VAL . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.755 0.312 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.596 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 66' ' ' THR . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HG3' HG12 ' A' ' 75' ' ' VAL . 12.2 mm-40 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 31' ' ' LEU . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 37' ' ' VAL . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 33' ' ' VAL . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.596 0.236 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HA ' HD13 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.641 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 71' ' ' TYR . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 72' ' ' PHE . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 73' ' ' LEU . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' VAL . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 38' ' ' VAL . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.388 0.137 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HA ' HD12 ' A' ' 63' ' ' LEU . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 66' ' ' THR . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.642 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 71' ' ' TYR . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' PHE . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 36' ' ' ILE . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 33' ' ' VAL . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 33' ' ' VAL . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 41' ' ' ALA . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.672 0.273 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.776 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 72' ' ' PHE . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 73' ' ' LEU . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 33' ' ' VAL . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 33' ' ' VAL . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CE1' HD23 ' A' ' 64' ' ' LEU . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 ' CE1' ' A' ' 61' ' ' PHE . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 71' ' ' TYR . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 73' ' ' LEU . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' HG21 ' A' ' 75' ' ' VAL . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.485 HG13 ' HZ2' ' A' ' 68' ' ' TRP . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.662 0.268 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.485 ' HZ2' HG13 ' A' ' 32' ' ' VAL . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' HG ' ' A' ' 31' ' ' LEU . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 73' ' ' LEU . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' HG12 ' A' ' 75' ' ' VAL . 28.8 mt-30 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . . . . . . 0 C--O 1.237 0.413 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 37' ' ' VAL . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 30' ' ' ALA . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 33' ' ' VAL . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.479 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 76' ' ' VAL . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 72' ' ' PHE . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 33' ' ' VAL . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 62' ' ' GLY . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' TYR . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . . . . . . 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 28' ' ' ALA . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HZ2' ' A' ' 68' ' ' TRP . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 41' ' ' ALA . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' HZ2' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' THR . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 28' ' ' ALA . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.47 0.176 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.467 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -49.39 122.77 6.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.324 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -150.08 169.63 20.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.914 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -137.75 -78.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.54 -26.91 4.61 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.206 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.691 HD22 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -70.82 60.72 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.152 0.501 . . . . 0.0 111.824 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 22' ' ' ARG . 3.6 p -128.89 -51.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mmt85 -151.46 102.51 2.9 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.951 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 32.0 65.32 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.927 0.491 . . . . 0.0 112.277 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.05 -155.02 0.55 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.538 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.5 OUTLIER 74.51 72.25 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.19 0.519 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.7 -48.71 16.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.966 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -39.7 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.584 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.75 -43.88 13.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.428 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 79' ' ' GLN . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.12 70.48 4.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.9 67.15 0.06 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.927 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.84 101.38 1.62 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.24 110.8 6.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.731 0.301 . . . . 0.0 111.699 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -141.93 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -157.56 -64.02 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -175.7 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.3 tt 40.31 50.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.85 55.4 9.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.44 -28.7 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.918 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 7.2 tp 42.0 71.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.477 0.655 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 82.25 141.03 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.385 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -57.7 -56.82 17.0 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.635 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CG ' HG23 ' A' ' 56' ' ' ILE . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' THR . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG12 HD22 ' A' ' 20' ' ' LEU . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' HD11 ' A' ' 18' ' ' LEU . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.433 ' HG3' ' CB ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 18' ' ' LEU . 9.3 mm100 -45.66 105.13 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.58 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -69.84 64.05 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 47.9 mt-10 -101.5 142.4 32.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.621 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 63.0 -67.55 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' HD23 ' A' ' 18' ' ' LEU . 8.4 t -122.72 116.75 24.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.795 0.331 . . . . 0.0 111.098 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HA ' HD23 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -50.3 121.98 6.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.894 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -137.35 -73.99 0.42 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.195 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 58.01 81.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.801 0.334 . . . . 0.0 111.464 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD22 ' CG ' ' A' ' 16' ' ' MET . 4.0 tp -127.77 62.36 1.4 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 112.031 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' HG3' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -140.44 147.27 39.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.302 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.231 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.402 0.144 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -146.12 153.3 40.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.774 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 22.6 ttmt -173.41 111.9 0.2 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -140.56 -66.45 0.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -59.96 85.55 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.977 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.643 HD11 ' NH2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER 38.97 59.89 1.54 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.757 0.423 . . . . 0.0 111.769 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 38.8 t 88.12 -19.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.732 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.778 ' HD2' HD13 ' A' ' 26' ' ' LEU . 53.0 mtm-85 -85.37 169.34 13.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.151 0.5 . . . . 0.0 111.843 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' MET . 5.1 m-85 -74.97 130.67 39.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t 65.88 177.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 63.49 8.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.147 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.778 HD13 ' HD2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -48.26 -39.92 23.03 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.668 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.7 tm? -47.75 -38.41 15.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.89 -39.03 11.39 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 87' ' ' LEU . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' LEU . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' VAL . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 55' ' ' VAL . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.85 63.87 7.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 0.6 OUTLIER -101.42 131.61 47.43 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.885 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.78 -144.15 3.85 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.585 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -72.55 95.62 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.666 0.27 . . . . 0.0 110.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.74 179.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.73 -49.26 3.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.3 m -53.28 -62.0 1.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.578 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 54' ' ' ASP . 4.0 tt -175.5 -57.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.566 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -134.47 -62.39 0.74 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.442 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 43' ' ' THR . 3.7 p -62.66 141.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 112.129 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.97 -67.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.237 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -80.28 64.66 5.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p -65.78 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' TYR . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -57.38 -64.8 0.77 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 78' ' ' GLU . 0.6 OUTLIER 35.69 38.02 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.96 -76.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.046 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.87 163.7 13.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.561 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -158.43 58.81 0.45 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.739 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -82.29 -27.99 32.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.342 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -53.0 19.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 -67.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.197 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.636 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -166.3 -56.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -100.89 150.74 22.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.065 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.502 0.191 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 152.63 45.36 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.25 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -99.71 -59.18 1.77 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HA ' HD22 ' A' ' 27' ' ' LEU . 1.4 tt -76.72 -57.21 3.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.476 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' VAL . . . 75.27 61.92 2.88 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.941 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 58.68 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 111.841 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 19' ' ' GLY . 46.7 t -147.22 -58.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -83.59 -32.63 25.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.658 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.23 154.58 46.93 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 26' ' ' LEU . 4.3 t -166.82 -173.08 2.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.468 ' HA ' ' OE1' ' A' ' 79' ' ' GLN . 0.7 OUTLIER 63.39 -65.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.5 mm? -65.0 -40.87 95.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.983 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 18' ' ' LEU . 3.9 mt -47.69 -33.55 7.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -32.93 14.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.326 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 38' ' ' VAL . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 75.36 0.38 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 154.17 43.7 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.42 -65.7 0.02 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.053 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -72.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.649 0.262 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.57 127.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.817 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.72 173.71 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t 59.66 -157.99 0.32 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.932 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.971 HG21 HD11 ' A' ' 56' ' ' ILE . 17.6 mt -143.55 122.56 7.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -62.07 154.14 27.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.792 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t 67.09 -65.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.888 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.971 HD11 HG21 ' A' ' 53' ' ' ILE . 12.5 pt -73.24 62.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -67.07 -47.75 70.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.017 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p -68.51 -57.83 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.784 HD13 HG22 ' A' ' 56' ' ' ILE . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.422 ' C ' HD23 ' A' ' 73' ' ' LEU . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' A' ' 87' ' ' LEU . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -71.64 81.56 0.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.68 112.03 0.15 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.87 -68.4 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.434 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 52.64 41.24 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.074 0.464 . . . . 0.0 111.144 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.8 t -127.11 -156.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.356 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 55.74 0.7 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 -173.96 2.42 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -70.79 55.48 0.17 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 111.576 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.764 ' HG ' HG22 ' A' ' 76' ' ' VAL . 14.5 tp 172.16 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.07 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -77.53 172.97 12.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.862 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.356 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.381 0.134 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -140.43 -51.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.717 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.0 mtpt 74.66 -165.29 0.09 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.837 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 81' ' ' GLU . 4.9 mp 71.43 -64.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.546 0.338 . . . . 0.0 111.593 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.13 94.52 0.07 OUTLIER Glycine 0 C--N 1.335 0.52 0 O-C-N 123.418 0.448 . . . . 0.0 113.467 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.4 83.08 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.02 -74.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.62 -51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.99 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -115.1 36.78 3.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.617 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.6 p -127.27 -83.49 0.61 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.85 60.37 5.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -42.85 90.0 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 mt -47.51 -31.4 4.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.529 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.1 -44.33 15.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 34' ' ' LEU . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' VAL . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 41' ' ' ALA . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.09 58.76 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 149.51 35.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.65 -61.22 0.67 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.164 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.7 -55.99 1.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 50' ' ' VAL . 6.8 p -155.42 68.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.06 -54.58 5.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 56' ' ' ILE . 68.3 m 58.91 65.02 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.939 0.399 . . . . 0.0 111.708 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -88.64 -33.62 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.506 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -99.87 -74.63 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.286 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 55' ' ' VAL . 3.5 m -76.96 60.48 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 110.915 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 4.8 tt -76.51 122.89 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 111.675 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 8.0 mtp85 -78.24 68.39 4.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -53.19 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.97 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.62 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA2' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' ILE . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' THR . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 87' ' ' LEU . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 73' ' ' LEU . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -71.61 -52.7 16.69 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.31 -67.96 0.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.038 0.535 . . . . 0.0 111.652 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 18' ' ' LEU . 6.1 mt-10 -133.55 -47.33 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.003 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.92 -62.3 0.32 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.69 -62.61 0.45 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.586 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.9 62.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.755 0.312 . . . . 0.0 111.643 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER 46.3 66.2 1.01 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.722 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 7.3 mpt_? 73.56 130.52 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.465 ' HB3' HG13 ' A' ' 75' ' ' VAL . 1.8 tp -77.95 -38.8 44.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.192 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.9 t -117.89 -167.97 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.242 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.621 -0.705 . . . . 0.0 111.28 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.2 158.59 22.05 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.731 0.301 . . . . 0.0 111.44 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.34 97.8 1.0 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.629 HD23 HG13 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -83.87 68.5 9.99 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.609 -179.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.34 65.25 0.25 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.292 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LEU . 1.8 pp -157.64 -41.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.432 0.293 . . . . 0.0 111.413 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG13 HD23 ' A' ' 18' ' ' LEU . 18.4 m -56.75 141.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -71.7 62.35 0.4 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.217 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.26 55.3 0.74 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 110.968 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.75 133.29 8.31 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 69.98 -60.85 0.47 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.284 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 12.0 mt -47.12 -49.5 21.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.672 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -51.51 -41.69 61.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.13 -32.36 64.17 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 38' ' ' VAL . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.84 134.92 43.38 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -59.97 0.5 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 -39.11 2.85 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.905 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.92 32.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 111.714 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' VAL . 8.4 p -89.28 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.269 0.557 . . . . 0.0 111.191 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -49.6 -37.7 28.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.554 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -104.75 99.5 9.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.693 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.92 -45.72 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 111.165 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.5 -67.27 0.95 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.2 t -141.27 132.05 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.805 0.335 . . . . 0.0 110.955 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' ILE . 6.0 tp -60.88 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER 62.63 87.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.501 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.37 -59.29 2.48 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.266 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' HE3' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' HD13 ' A' ' 64' ' ' LEU . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 76' ' ' VAL . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 72' ' ' PHE . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 73' ' ' LEU . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 87' ' ' LEU . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 17.5 tt0 -68.69 -19.42 64.38 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER 66.18 97.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -116.12 -60.49 1.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.724 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -81.33 -79.3 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -79.65 178.23 8.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.21 0.528 . . . . 0.0 111.925 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -98.71 63.17 1.41 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.882 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -66.87 -44.2 81.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.827 0.346 . . . . 0.0 110.068 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 69.29 84.28 0.15 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.684 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -124.29 -77.16 0.59 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.279 178.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 54.6 p -109.95 -81.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.959 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.577 0.751 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.522 0.201 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.521 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 2.4 mpp? -74.35 86.08 1.98 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 16' ' ' MET . 57.2 mttt 81.42 130.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.015 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 3.7 mm? -72.67 -51.44 19.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.26 -90.52 0.83 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.236 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 tp -103.93 -63.13 1.22 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.758 0.314 . . . . 0.0 111.081 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t 67.85 40.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.941 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -95.18 -42.42 8.58 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.468 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.73 78.6 1.64 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.658 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p 71.0 -176.82 0.2 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.793 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.404 ' HG2' ' CG1' ' A' ' 76' ' ' VAL . 4.1 tpt -76.22 64.71 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.44 -46.16 56.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.497 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 80' ' ' LEU . 2.8 mm? -46.9 -34.11 5.16 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.82 11.73 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 82' ' ' GLU . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 84.48 1.18 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -39.2 116.32 0.58 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.406 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.5 -66.18 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.49 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.62 143.17 50.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.559 0.219 . . . . 0.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -52.0 -48.51 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.922 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.15 101.1 0.53 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.238 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.31 169.23 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 53' ' ' ILE . 7.0 mt -88.52 1.9 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.757 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' VAL . 2.8 t70 -119.05 169.3 10.04 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -165.16 -47.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.053 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 57' ' ' ARG . 3.1 tt -160.31 -45.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.672 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' HG23 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.68 57.37 1.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.045 0.45 . . . . 0.0 110.9 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t -65.3 -50.67 64.8 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 71' ' ' TYR . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 72' ' ' PHE . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.14 164.93 12.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -113.35 -65.08 1.22 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.586 0.231 . . . . 0.0 111.36 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 139.11 47.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.138 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HB1' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 55.59 -164.21 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 10.1 t -121.15 -40.73 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -70.04 94.46 0.87 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.452 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 0.6 OUTLIER 75.45 115.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.23 92.6 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.327 0.584 . . . . 0.0 111.777 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.46 162.9 40.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.874 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t 69.66 172.32 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 111.446 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.335 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 82' ' ' GLU . 10.8 tmm? . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.02 -58.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.546 0.338 . . . . 0.0 111.718 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -123.55 75.13 1.3 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.95 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 6.9 tt -138.59 129.21 26.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.32 105.7 0.86 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.242 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 21' ' ' VAL . 3.0 tm? -49.89 -41.63 46.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.809 0.338 . . . . 0.0 110.77 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -120.48 83.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.7 ttt180 91.84 154.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.983 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -52.31 144.11 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.87 157.99 0.17 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.032 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.403 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 44.6 ttm -74.21 74.58 1.8 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.463 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mp -50.3 -36.17 30.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tp -49.46 -33.98 15.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 -35.93 2.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 37' ' ' VAL . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 33' ' ' VAL . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 33' ' ' VAL . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 50' ' ' VAL . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -63.77 127.66 32.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -56.24 -35.52 67.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.3 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.05 124.11 6.4 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.041 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.73 105.99 0.51 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 111.584 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' HA ' HG23 ' A' ' 43' ' ' THR . 21.4 t 78.56 129.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.689 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 59.2 0.86 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.214 0.53 . . . . 0.0 110.791 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.6 p -177.95 43.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.95 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 pt -75.13 -31.09 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.69 -57.19 6.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.4 86.99 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 56' ' ' ILE . 19.4 tt -81.64 97.07 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.324 0.583 . . . . 0.0 111.049 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 2.7 mmm-85 -135.0 128.71 32.91 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.325 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -56.76 -60.23 3.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.879 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.669 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 66' ' ' THR . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 73' ' ' LEU . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -47.38 107.6 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.71 90.42 2.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -62.22 -179.11 0.2 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.221 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 18' ' ' LEU . 22.3 mt-10 68.27 -57.74 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.198 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.5 p -51.68 135.76 28.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.835 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -72.54 63.57 0.58 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 110.837 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 1.8 tt0 75.15 136.13 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -98.44 -39.0 8.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.758 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.51 -53.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -157.79 -166.37 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.488 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.389 0.138 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.22 153.71 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.993 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.54 57.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.385 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HB3' HD21 ' A' ' 20' ' ' LEU . 1.8 mp -94.38 123.26 37.68 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.891 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.07 66.48 0.5 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.257 -0.496 . . . . 0.0 113.336 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -157.08 -65.32 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.521 0.201 . . . . 0.0 111.193 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 22' ' ' ARG . 40.7 t -130.68 -72.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HG2' HG12 ' A' ' 21' ' ' VAL . 25.2 ptt180 -175.91 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.35 40.69 1.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' CB ' ' HG3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -121.71 175.32 6.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.644 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.14 63.25 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.408 0.623 . . . . 0.0 111.991 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.1 -34.43 78.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.292 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tp -47.46 -36.9 10.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.91 10.2 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 33' ' ' VAL . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 38' ' ' VAL . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.691 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -52.22 63.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -163.39 67.59 0.19 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.016 0.436 . . . . 0.0 110.646 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 44' ' ' MET . . . -82.38 -107.49 0.43 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.375 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 6.8 mt-30 54.56 66.01 1.35 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.414 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 59.4 t 85.11 -41.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.196 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER 66.05 -63.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.5 p -168.63 120.81 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.657 0.265 . . . . 0.0 111.203 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 54' ' ' ASP . 1.6 pp -56.72 -35.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.097 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.3 t0 -127.04 177.29 6.74 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.013 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 58' ' ' SER . 13.0 p -71.15 58.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.532 0.682 . . . . 0.0 111.408 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.505 HG23 ' HG3' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -60.37 -35.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.486 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 56' ' ' ILE . 66.0 mtt-85 -97.44 31.32 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.702 ' HB2' HG22 ' A' ' 55' ' ' VAL . 39.0 t -53.19 -62.86 1.38 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.255 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.5 HD13 ' HE3' ' A' ' 68' ' ' TRP . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.5 ' HE3' HD13 ' A' ' 65' ' ' ILE . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 71' ' ' TYR . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.618 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -92.64 -170.89 2.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.73 174.56 8.33 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -69.43 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.518 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 24' ' ' SER . 5.0 tt0 -150.44 -49.82 0.13 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 m -75.85 -69.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.094 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.16 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.975 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -152.32 34.15 0.52 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.429 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD2' ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -175.17 159.37 2.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.23 128.13 54.45 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.845 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 p -148.2 172.35 14.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.326 0.108 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.45 150.0 49.72 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.122 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -74.48 66.08 1.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.107 0.479 . . . . 0.0 111.643 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mp -78.65 61.68 3.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.678 ' HA3' HG11 ' A' ' 76' ' ' VAL . . . 71.76 -71.5 0.89 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.55 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 24' ' ' SER . 0.2 OUTLIER -81.29 141.37 34.14 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.636 0.255 . . . . 0.0 110.892 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.64 -32.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.537 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -107.58 173.1 6.47 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.339 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.81 61.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.117 0.484 . . . . 0.0 111.738 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . 28.3 t -100.63 -160.89 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.794 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 79' ' ' GLN . 4.5 tpt 54.06 42.4 31.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.851 0.357 . . . . 0.0 111.307 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 pp -44.37 -37.27 3.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.072 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.99 -35.63 11.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.77 -41.76 15.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 38' ' ' VAL . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 51' ' ' GLU . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -84.74 -176.4 6.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -50.18 -45.97 53.88 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.41 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.27 -99.58 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.041 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.73 -57.35 0.51 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 111.537 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -150.07 117.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.763 0.316 . . . . 0.0 111.292 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HG3' HG21 ' A' ' 43' ' ' THR . 18.0 mp0 -69.91 58.53 0.15 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.457 ' CB ' HG12 ' A' ' 56' ' ' ILE . 1.2 m 59.48 84.71 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.578 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.603 HG12 ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -102.65 -75.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.1 -45.15 3.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -37.37 -46.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG12 ' CB ' ' A' ' 52' ' ' SER . 1.5 pp -94.48 134.03 33.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 111.146 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -71.58 92.89 1.17 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.62 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p -31.75 -55.54 0.28 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.096 0.558 . . . . 0.0 112.46 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.886 HG12 ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.678 HG11 ' HA3' ' A' ' 19' ' ' GLY . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 87' ' ' LEU . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.886 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -112.57 121.51 45.0 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD22 ' HG2' ' A' ' 89' ' ' ARG . 2.4 pp -65.99 133.01 49.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -116.39 169.27 9.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.69 52.07 1.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.987 0.423 . . . . 0.0 111.401 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.434 ' OG ' ' NH1' ' A' ' 84' ' ' ARG . 4.5 t -133.12 -59.09 0.89 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' NH1' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -165.54 29.11 0.05 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.0 -179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.57 170.52 0.26 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.099 0.476 . . . . 0.0 111.136 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.9 mmm180 -131.24 -103.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.61 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 77' ' ' VAL . 1.1 mt -90.89 89.37 7.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.769 0.319 . . . . 0.0 110.681 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.84 -50.16 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.655 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG2' HD22 ' A' ' 80' ' ' LEU . 3.4 tpt85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.385 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.47 0.176 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.21 175.7 5.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 138.75 52.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -164.77 162.9 21.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.03 -139.37 2.5 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' CD ' ' A' ' 81' ' ' GLU . 12.2 tp -71.33 70.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.299 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.11 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.333 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -107.15 -54.69 2.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.91 131.37 42.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 t 73.06 160.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.536 . . . . 0.0 112.029 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.8 mtt -82.93 69.2 9.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.756 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.32 -42.12 98.15 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.682 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 HE22 ' A' ' 79' ' ' GLN . 0.5 OUTLIER -42.36 -39.15 2.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.03 17.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.909 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 33' ' ' VAL . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 34' ' ' LEU . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' OE1' ' A' ' 51' ' ' GLU . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -58.59 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.36 46.41 26.38 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.25 -167.39 12.47 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.501 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.75 -67.93 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.606 0.362 . . . . 0.0 111.665 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.1 t -136.45 100.67 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' OE1' HG23 ' A' ' 43' ' ' THR . 2.3 mt-10 -147.28 -69.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.4 p -137.13 79.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.674 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.23 178.51 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.98 -172.6 0.19 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -80.06 66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 tp -101.2 -40.05 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.106 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 59.43 79.84 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.75 0.31 . . . . 0.0 111.5 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t -28.39 -49.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 76' ' ' VAL . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 72' ' ' PHE . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.439 HE22 HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -66.44 70.38 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.44 -58.58 7.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' HD22 ' A' ' 20' ' ' LEU . 2.2 tt0 -158.58 88.44 0.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.4 tt0 76.91 159.6 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.054 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER 73.69 144.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 65.5 54.78 1.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.345 0.593 . . . . 0.0 110.277 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -82.67 -35.85 26.47 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.422 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -97.03 -54.78 3.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.32 -69.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -37.51 10.44 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.283 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 16' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.313 0.101 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 69.08 -64.2 0.34 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' HE2' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -112.25 -64.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 69.81 -178.12 0.22 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.872 0.368 . . . . 0.0 111.258 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 25' ' ' MET . . . -174.06 59.98 0.13 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.631 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER 83.21 145.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.155 0.582 . . . . 0.0 111.641 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 21' ' ' VAL . 14.5 p -78.95 62.68 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.377 0.608 . . . . 0.0 111.477 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.21 58.88 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 111.031 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 71.88 -64.39 0.39 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.546 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -131.94 -163.58 1.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.625 0.25 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.716 ' SD ' HG13 ' A' ' 76' ' ' VAL . 21.1 ttt -66.73 95.07 0.33 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.629 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 20' ' ' LEU . 5.0 tp -49.27 -46.54 46.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.278 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 27' ' ' LEU . 3.4 mm? -54.54 -38.25 66.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.76 54.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.713 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 38' ' ' VAL . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.815 HG21 ' HA ' ' A' ' 51' ' ' GLU . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.53 77.67 7.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.6 t60 77.22 -55.57 0.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.38 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . 127.49 -135.52 8.79 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.111 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mp0 68.42 -179.54 0.23 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.666 0.27 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 51' ' ' GLU . 15.5 m -68.82 -43.59 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.815 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -166.36 -52.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.432 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.5 p -120.09 155.69 32.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.337 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.07 -44.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -169.08 -68.02 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.154 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 m -68.84 62.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.165 0.507 . . . . 0.0 111.49 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.5 tp -122.42 142.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.235 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 mtp180 -125.88 102.87 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t -44.49 -48.99 10.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.596 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 66' ' ' THR . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 ' SD ' ' A' ' 25' ' ' MET . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 80' ' ' LEU . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HG3' HG12 ' A' ' 75' ' ' VAL . 12.2 mm-40 -55.49 -56.86 15.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER 56.8 -158.7 0.25 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.13 53.8 1.28 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.177 0.513 . . . . 0.0 110.657 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.38 -58.73 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.32 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -44.65 114.88 0.77 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.142 0.496 . . . . 0.0 111.93 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -84.36 61.49 6.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.79 30.63 6.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.317 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -105.23 135.82 45.88 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.88 -45.89 11.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.991 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 m -169.22 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.032 -0.985 . . . . 0.0 111.613 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.386 0.136 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -122.32 162.18 21.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 16' ' ' MET . 40.7 mttm 73.48 154.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.704 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -146.05 178.94 7.83 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 67.62 1.14 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.8 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 70.33 173.83 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 22' ' ' ARG . 30.0 m -93.93 -39.71 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG23 ' A' ' 21' ' ' VAL . 39.5 ptt85 -142.15 -48.38 0.36 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.93 -24.04 56.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.8 t 68.87 -162.74 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.713 0.292 . . . . 0.0 111.292 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.417 ' CE ' HG13 ' A' ' 76' ' ' VAL . 55.6 mtm -109.01 111.64 23.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 26' ' ' LEU . 2.7 mm? -52.34 -42.97 64.34 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.987 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.53 -44.73 46.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.64 -34.17 36.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.555 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 31' ' ' LEU . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 37' ' ' VAL . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 33' ' ' VAL . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.469 ' HA ' ' C ' ' A' ' 48' ' ' GLY . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.49 -50.44 63.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.0 -59.06 0.8 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.709 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 44' ' ' MET . . . 170.92 173.62 38.17 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.971 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' CA ' ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -75.04 69.05 1.91 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.95 127.82 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.578 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' SER . 8.4 mm-40 -79.04 80.01 5.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 63.6 m 74.98 168.21 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.074 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 53' ' ' ILE . 8.2 tt -128.89 118.53 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 47.32 48.42 16.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.1 p -160.25 101.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.044 0.45 . . . . 0.0 111.491 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 56' ' ' ILE . 9.2 tt -77.12 65.69 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.494 0.664 . . . . 0.0 111.415 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -85.12 62.08 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.344 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -69.51 -69.02 0.37 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.762 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HA ' HD13 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.641 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 71' ' ' TYR . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 72' ' ' PHE . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 73' ' ' LEU . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.29 64.06 0.25 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -44.5 6.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.352 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.52 112.97 23.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.809 0.338 . . . . 0.0 111.745 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.44 139.64 52.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.001 0.429 . . . . 0.0 111.163 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -172.16 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.78 -56.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.197 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 58.95 -171.66 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.959 0.409 . . . . 0.0 111.594 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.2 173.89 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HG22 ' A' ' 75' ' ' VAL . 3.8 m -101.06 -50.67 3.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.943 -179.671 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.4 mtp -148.79 -81.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.134 0.271 . . . . 0.0 111.026 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tttp 75.04 120.02 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.16 -164.08 0.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.987 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 28' ' ' ALA . . . -75.06 110.93 3.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 21' ' ' VAL . 6.3 tt 75.95 -63.25 0.4 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.573 0.349 . . . . 0.0 110.936 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 20' ' ' LEU . 7.0 p -171.61 -43.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 66.15 0.92 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 111.507 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 t80 67.27 69.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.698 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 1.8 m -134.34 -56.57 0.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.2 mtt -88.29 116.61 26.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 110.75 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -58.37 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.965 HD22 ' HB3' ' A' ' 79' ' ' GLN . 1.6 mp -38.72 -41.64 0.73 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.534 ' CB ' ' HA2' ' A' ' 19' ' ' GLY . . . -45.8 -42.43 12.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' VAL . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 38' ' ' VAL . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 157.93 9.65 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.63 -31.61 70.8 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.64 -173.78 37.44 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.01 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.81 117.58 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.305 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.26 -70.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -111.28 120.88 43.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.083 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' A' ' 56' ' ' ILE . 4.4 m -167.57 45.97 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.934 0.397 . . . . 0.0 111.399 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 54' ' ' ASP . 9.3 tt -162.29 -47.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 53' ' ' ILE . 1.5 m-20 -56.73 -70.72 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.7 0.285 . . . . 0.0 111.532 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.25 22.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.76 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' SER . 24.8 mm -103.84 80.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.013 0.435 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.56 35.47 22.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.14 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 5.7 p -59.19 -64.33 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.095 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HA ' HD12 ' A' ' 63' ' ' LEU . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 66' ' ' THR . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.642 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 71' ' ' TYR . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' PHE . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 80' ' ' LEU . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.965 ' HB3' HD22 ' A' ' 27' ' ' LEU . 65.2 mt-30 -58.27 -75.87 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 77' ' ' VAL . 0.8 OUTLIER 34.26 34.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.684 ' O ' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -139.3 98.02 3.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 110.927 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.21 69.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.678 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -78.27 -175.43 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.844 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -53.63 8.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.465 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.8 OUTLIER -174.73 155.41 2.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.986 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 33.26 74.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.588 0.555 . . . . 0.0 112.108 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 81' ' ' GLU . 44.2 tp -81.95 -56.65 3.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t -76.68 153.29 35.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.098 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.216 0.055 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 1.3 ttm 72.27 166.6 0.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.246 0.342 . . . . 0.0 111.285 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.51 35.51 4.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.24 106.06 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.33 -81.3 0.2 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.577 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -96.27 -75.91 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 22' ' ' ARG . 2.8 t -123.65 -53.83 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' HD3' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -159.81 -57.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.11 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.5 90.17 3.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.288 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m -154.08 169.26 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.57 45.23 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tp -42.81 -38.97 2.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.818 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 85' ' ' GLN . 5.0 mp -44.34 -39.15 4.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.446 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.42 -48.38 26.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 36' ' ' ILE . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 33' ' ' VAL . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 33' ' ' VAL . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 41' ' ' ALA . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 53' ' ' ILE . 3.5 tt -84.69 78.3 9.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 78.66 0.12 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.36 -22.4 58.62 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.681 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt-30 -79.17 150.84 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.058 0.429 . . . . 0.0 110.834 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 37.2 t 78.97 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -45.23 -40.38 7.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -144.45 46.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 46' ' ' LEU . 3.4 mp 69.0 -58.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.436 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.83 -171.33 3.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.877 0.37 . . . . 0.0 111.361 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 m -70.49 69.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -86.47 150.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.261 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 60' ' ' PHE . 1.5 mpp_? -90.08 128.74 36.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p -60.64 -65.18 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.608 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 57' ' ' ARG . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.776 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG13 ' HG2' ' A' ' 89' ' ' ARG . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 72' ' ' PHE . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 73' ' ' LEU . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -80.69 66.87 6.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 tt -72.22 72.93 0.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.522 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.18 -60.0 0.5 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.479 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -61.65 0.46 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.529 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 14.8 t -176.52 -178.85 0.96 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 111.822 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -77.49 75.91 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.591 ' N ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 65.29 59.14 0.83 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.247 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -88.43 -59.88 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.722 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' HD3' ' A' ' 86' ' ' ARG . 4.0 pp -140.87 159.05 43.04 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.498 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -175.85 5.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG2' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.16 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.569 0.223 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.8 mmt -75.76 165.45 25.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.166 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 133.02 35.42 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.281 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 HD22 ' SD ' ' A' ' 25' ' ' MET . 0.2 OUTLIER -108.8 -53.06 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.47 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' PHE . . . -72.5 104.35 1.5 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tt -41.5 -56.46 2.53 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.7 p -97.0 106.93 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.894 0.378 . . . . 0.0 111.661 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 49.25 40.75 18.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.291 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 26' ' ' LEU . 98.9 m-85 59.77 35.6 22.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 21' ' ' VAL . 31.4 t -46.89 -64.39 0.79 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.467 ' SD ' HD22 ' A' ' 18' ' ' LEU . 2.1 ttm -59.84 -51.42 69.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.877 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 23' ' ' PHE . 5.4 tt -49.08 -40.61 32.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.058 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -44.7 -35.6 2.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.298 179.429 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.75 -37.94 31.67 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 33' ' ' VAL . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 33' ' ' VAL . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -75.21 -179.25 4.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.73 63.4 1.15 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.51 -64.31 2.52 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 71.89 171.42 0.31 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.503 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.5 p -81.12 72.63 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.622 0.725 . . . . 0.0 110.934 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.35 -47.95 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.768 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . 10.3 m -50.33 153.96 1.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.731 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.28 -49.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -87.36 -49.83 6.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 110.241 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.24 169.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.761 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.11 65.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.109 0.481 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -107.04 -26.18 11.27 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -50.57 -57.5 8.01 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CE1' HD23 ' A' ' 64' ' ' LEU . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 ' CE1' ' A' ' 61' ' ' PHE . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 71' ' ' TYR . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 84' ' ' ARG . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 73' ' ' LEU . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 81' ' ' GLU . 29.2 tt0 -58.09 109.89 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.9 67.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.119 0.485 . . . . 0.0 111.224 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -166.42 -179.8 5.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.588 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -73.58 -79.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.839 -0.164 . . . . 0.0 110.609 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t 62.41 -62.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.797 0.332 . . . . 0.0 111.467 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.81 ' HB2' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.04 64.26 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 1.2 mp0 74.22 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.299 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 84.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.302 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.89 84.48 2.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.446 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -108.81 117.14 33.42 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.28 153.07 39.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.943 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 80' ' ' LEU . 4.4 pttt -164.62 86.64 0.45 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.33 165.75 30.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 25' ' ' MET . . . -114.18 -52.45 0.45 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.833 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD22 HD12 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -112.81 -58.45 2.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.455 0.169 . . . . 0.0 111.264 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.88 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -142.33 51.81 1.46 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' SER . 6.2 p90 -161.27 52.84 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.642 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 52.0 m 71.58 175.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.446 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 2.0 mpp? -96.11 66.08 2.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD22 ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.81 -26.05 63.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.687 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -47.8 -37.78 14.36 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.1 26.79 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 88' ' ' SER . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' HG21 ' A' ' 75' ' ' VAL . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.485 HG13 ' HZ2' ' A' ' 68' ' ' TRP . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 117.51 4.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.48 70.32 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.149 0.499 . . . . 0.0 111.004 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 148.54 123.87 1.35 Allowed Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.172 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -65.12 152.11 44.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.401 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.9 m -68.63 64.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.995 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.31 30.92 13.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.637 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.2 p -154.01 99.7 2.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.452 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 54' ' ' ASP . 3.7 tp -121.05 -53.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' HG23 ' A' ' 53' ' ' ILE . 31.6 m-20 -112.31 29.62 7.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.695 0.283 . . . . 0.0 111.589 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.13 133.04 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.77 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.4 mm -73.08 -50.55 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER 50.94 48.52 22.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.636 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t -44.77 -51.79 9.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.316 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.485 ' HZ2' HG13 ' A' ' 32' ' ' VAL . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' HG ' ' A' ' 31' ' ' LEU . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 73' ' ' LEU . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' HG12 ' A' ' 75' ' ' VAL . 28.8 mt-30 -61.5 -39.15 89.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -52.47 -44.73 65.76 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.321 178.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -79.71 -41.93 25.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.758 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.6 -165.14 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.634 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 45.54 50.92 10.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -116.16 -64.67 1.28 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.21 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -157.36 -79.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 179.65 140.67 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.028 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.13 -41.43 2.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.757 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 20.8 t -174.02 -50.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.162 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 O-C-N 123.849 0.718 . . . . 0.0 111.695 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.312 0.101 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.39 137.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.301 0.376 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 77' ' ' VAL . 4.7 mtmt 55.94 79.11 0.17 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.943 0.401 . . . . 0.0 111.6 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.34 -59.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.038 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.18 -173.55 22.93 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 24.21 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.807 0.337 . . . . 0.0 111.694 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.019 HG21 HD13 ' A' ' 27' ' ' LEU . 24.3 t -125.23 87.9 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 111.1 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.94 -149.33 0.44 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.24 -38.91 6.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -73.86 -13.24 60.89 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.5 mmt 54.45 51.33 14.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -39.72 -39.26 0.75 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.471 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.019 HD13 HG21 ' A' ' 21' ' ' VAL . 4.0 mp -42.81 -39.47 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -47.46 -34.53 7.43 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.816 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 37' ' ' VAL . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.843 HD11 ' HG3' ' A' ' 85' ' ' GLN . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 33' ' ' VAL . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 50' ' ' VAL . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.797 ' HA ' HG23 ' A' ' 50' ' ' VAL . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.46 160.5 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -128.74 88.71 2.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.668 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.46 79.98 1.24 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.369 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.79 -75.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.139 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 43' ' ' THR . 6.4 m -77.39 62.72 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.881 0.372 . . . . 0.0 111.637 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -157.07 179.22 9.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.3 72.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.218 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.85 -51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.376 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.59 -42.07 59.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 111.065 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.22 85.45 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.213 0.53 . . . . 0.0 110.49 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.19 128.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.642 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 2.7 ttt180 71.99 109.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.835 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p -49.3 -52.73 25.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.479 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.672 HG13 HD23 ' A' ' 87' ' ' LEU . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 ' HA ' ' A' ' 17' ' ' LYS . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -54.93 126.43 24.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.48 -162.82 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.632 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.3 tt0 -72.66 61.76 0.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.08 0.466 . . . . 0.0 111.591 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -112.71 -71.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.204 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.55 ' HB2' ' HG ' ' A' ' 27' ' ' LEU . 7.1 t 66.82 -161.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' NH1' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 58.82 61.92 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.684 -179.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.843 ' HG3' HD11 ' A' ' 34' ' ' LEU . 1.9 tt0 65.44 -161.8 0.26 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.662 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.24 174.9 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.59 0.233 . . . . 0.0 111.342 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.672 HD23 HG13 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 33.95 65.85 0.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.191 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 1.4 t -146.25 94.0 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.378 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 17.6 tpp85 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.612 -0.708 . . . . 0.0 111.103 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -130.56 171.92 12.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.68 124.47 42.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.58 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.39 -72.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.82 129.39 2.4 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.688 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER 52.95 -173.48 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG23 ' HG ' ' A' ' 20' ' ' LEU . 97.7 t 71.41 121.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.936 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.12 150.52 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -49.87 104.05 0.06 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -177.64 -61.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.516 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.95 115.53 13.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.434 179.448 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 pp -112.02 -34.16 6.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.837 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -41.91 -42.42 2.75 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . . . -39.8 -40.47 0.97 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.459 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 49' ' ' GLN . 2.6 tt -63.67 123.17 18.17 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.88 154.23 42.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.792 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 -55.89 4.79 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.589 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -72.83 68.31 0.87 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.693 0.282 . . . . 0.0 111.266 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.6 p 41.16 71.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.615 0.721 . . . . 0.0 112.414 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 53' ' ' ILE . 1.7 pm0 -69.85 63.53 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.5 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.11 35.45 24.79 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.813 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 51' ' ' GLU . 2.4 pp -94.96 -34.47 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -68.27 0.63 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.949 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 m -74.91 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.262 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 53' ' ' ILE . 3.6 pt -76.55 64.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.457 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -123.23 60.92 1.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.348 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t -52.98 -51.39 61.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.591 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 76' ' ' VAL . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 72' ' ' PHE . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -126.96 145.67 50.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.9 tp -97.91 -67.23 0.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.788 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 87' ' ' LEU . 1.4 mp0 -102.72 69.14 1.06 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 110.598 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -58.3 133.26 55.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.726 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m 178.13 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.468 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.48 -42.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -142.24 -50.84 0.39 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' HA ' ' CD ' ' A' ' 79' ' ' GLN . 3.9 ptp180 -171.54 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 6.3 mp -115.43 156.87 24.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.619 0.247 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -54.71 98.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.381 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.422 0.153 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.439 ' O ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -133.93 172.17 13.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.832 0.349 . . . . 0.0 111.515 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -165.21 117.6 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.122 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.77 137.52 7.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.53 51.48 4.58 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.074 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tp 76.39 -156.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.543 0.337 . . . . 0.0 111.521 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG12 ' HG3' ' A' ' 22' ' ' ARG . 61.0 t -73.87 -70.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG3' HG12 ' A' ' 21' ' ' VAL . 60.6 mtm-85 -150.46 120.35 7.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.165 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 68.57 101.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.027 0.441 . . . . 0.0 111.398 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -169.88 -178.81 3.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.618 ' SD ' HG13 ' A' ' 76' ' ' VAL . 3.1 ttt 55.45 57.87 5.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.95 -40.09 6.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -40.72 -44.37 2.17 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.785 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -47.09 -49.23 22.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 33' ' ' VAL . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -58.7 7.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.69 109.29 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.043 0.449 . . . . 0.0 111.889 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.76 -90.68 0.08 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.053 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -137.8 -64.68 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.601 0.239 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -139.76 155.64 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.139 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 117.69 5.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.629 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 56' ' ' ILE . 5.4 m -174.8 129.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 111.771 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 53' ' ' ILE . 1.7 pp -97.2 -39.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.75 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -104.77 -71.02 0.75 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.791 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 p -121.14 142.69 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.452 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 3.8 pt -74.92 90.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 110.979 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -147.12 76.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.477 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t -61.87 -50.77 70.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.458 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 62' ' ' GLY . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' TYR . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' SD ' ' A' ' 25' ' ' MET . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.35 91.85 0.77 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tp -50.14 112.39 0.67 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.92 57.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.677 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.49 -78.69 0.14 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.265 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -97.66 142.48 29.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.415 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.95 -174.44 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.53 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.16 -169.19 2.98 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.43 117.21 3.13 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.973 0.415 . . . . 0.0 111.354 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.36 45.67 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.534 ' OG ' ' HD3' ' A' ' 89' ' ' ARG . 47.9 t -121.21 -54.0 2.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.814 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 111.501 0.185 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -119.01 177.1 4.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.625 0.25 . . . . 0.0 110.907 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -71.85 -65.98 0.7 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.41 46.9 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.45 44.85 7.71 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -71.84 142.35 49.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.244 0.545 . . . . 0.0 111.898 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.623 HG12 ' HG2' ' A' ' 22' ' ' ARG . 57.2 t -70.69 137.26 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.747 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.623 ' HG2' HG12 ' A' ' 21' ' ' VAL . 3.0 mmt180 70.18 79.07 0.19 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.752 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 78.9 m-85 75.6 96.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.278 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 42.4 t -142.9 148.72 37.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.544 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.618 ' SD ' ' HA ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER 59.41 49.8 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.019 0.438 . . . . 0.0 111.014 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.01 -40.42 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.65 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -47.05 -30.96 2.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.183 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -45.66 -38.3 6.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 28' ' ' ALA . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HZ2' ' A' ' 68' ' ' TRP . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 41' ' ' ALA . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.34 116.24 15.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 163.02 29.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.36 45.39 4.38 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.102 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -177.86 5.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 111.224 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' CG2' HD11 ' A' ' 56' ' ' ILE . 22.6 m -77.93 -157.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.74 100.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t 72.9 149.16 0.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.412 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.28 65.3 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.247 0.546 . . . . 0.0 110.886 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -170.08 -172.75 1.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.841 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ARG . 93.7 t -79.48 140.33 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.387 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 50' ' ' VAL . 32.7 mm -65.54 70.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.334 0.587 . . . . 0.0 111.142 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -175.36 90.41 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.573 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t -48.82 -51.01 31.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' HZ2' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' THR . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG13 ' HG2' ' A' ' 25' ' ' MET . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.524 HE22 HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -53.56 -42.8 67.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.618 ' HA ' ' SD ' ' A' ' 25' ' ' MET . 0.2 OUTLIER 50.17 -96.49 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.127 0.267 . . . . 0.0 110.997 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.5 mt-10 -171.57 40.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -86.02 64.45 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.472 ' O ' HD21 ' A' ' 27' ' ' LEU . 20.9 t 57.36 -153.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.673 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 113.82 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.189 -0.319 . . . . 0.0 110.95 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.48 111.89 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.47 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -75.81 -21.35 57.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.64 77.75 1.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.027 0.442 . . . . 0.0 111.209 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.4 p -58.8 -46.7 86.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.702 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 120.46 0.172 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 79' ' ' GLN . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' THR . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 72' ' ' PHE . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' CD ' HD11 ' A' ' 31' ' ' LEU . 9.3 mm100 . . . . . 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' LEU . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' VAL . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p . . . . . 0 N--CA 1.464 0.25 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' TYR . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 120.456 0.17 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 38' ' ' VAL . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.684 0.278 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 59' ' ' ILE . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.422 ' C ' HD23 ' A' ' 73' ' ' LEU . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 72' ' ' PHE . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.431 0.158 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 34' ' ' LEU . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' VAL . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 41' ' ' ALA . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.62 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA2' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' ILE . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' THR . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 73' ' ' LEU . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 38' ' ' VAL . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.63 0.253 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' HE3' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' HD13 ' A' ' 64' ' ' LEU . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 76' ' ' VAL . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 72' ' ' PHE . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 73' ' ' LEU . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 71' ' ' TYR . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 72' ' ' PHE . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 37' ' ' VAL . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 33' ' ' VAL . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 33' ' ' VAL . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.752 0.311 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.669 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 66' ' ' THR . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 73' ' ' LEU . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.492 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 33' ' ' VAL . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 38' ' ' VAL . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.0 t . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.557 0.218 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.5 HD13 ' HE3' ' A' ' 68' ' ' TRP . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.5 ' HE3' HD13 ' A' ' 65' ' ' ILE . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 71' ' ' TYR . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 76' ' ' VAL . 2.8 pt20 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 38' ' ' VAL . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.886 HG12 ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 72' ' ' PHE . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 73' ' ' LEU . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.886 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 33' ' ' VAL . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 34' ' ' LEU . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 76' ' ' VAL . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 72' ' ' PHE . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 38' ' ' VAL . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.468 0.466 0 CA-C-O 120.755 0.312 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.596 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 66' ' ' THR . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HG3' HG12 ' A' ' 75' ' ' VAL . 12.2 mm-40 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.415 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 31' ' ' LEU . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 37' ' ' VAL . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 33' ' ' VAL . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.596 0.236 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HA ' HD13 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.641 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 71' ' ' TYR . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 72' ' ' PHE . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 73' ' ' LEU . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 31' ' ' LEU . . . . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' VAL . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 38' ' ' VAL . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.388 0.137 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HA ' HD12 ' A' ' 63' ' ' LEU . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 66' ' ' THR . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.642 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 71' ' ' TYR . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' PHE . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 . . . . . 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.721 0.296 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 36' ' ' ILE . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 33' ' ' VAL . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 33' ' ' VAL . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 41' ' ' ALA . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 120.672 0.273 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.776 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 72' ' ' PHE . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 73' ' ' LEU . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 33' ' ' VAL . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 33' ' ' VAL . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CE1' HD23 ' A' ' 64' ' ' LEU . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 ' CE1' ' A' ' 61' ' ' PHE . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 71' ' ' TYR . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 73' ' ' LEU . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' HG21 ' A' ' 75' ' ' VAL . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.485 HG13 ' HZ2' ' A' ' 68' ' ' TRP . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 120.662 0.268 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.485 ' HZ2' HG13 ' A' ' 32' ' ' VAL . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' HG ' ' A' ' 31' ' ' LEU . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 73' ' ' LEU . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' HG12 ' A' ' 75' ' ' VAL . 28.8 mt-30 . . . . . 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . . . . . . 0 C--O 1.237 0.413 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 37' ' ' VAL . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 30' ' ' ALA . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 33' ' ' VAL . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 120.75 0.309 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.479 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.459 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.613 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 76' ' ' VAL . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 72' ' ' PHE . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 33' ' ' VAL . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 62' ' ' GLY . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' TYR . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? . . . . . 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . . . . . . 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 28' ' ' ALA . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HZ2' ' A' ' 68' ' ' TRP . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 41' ' ' ALA . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.424 ' HZ2' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' THR . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 28' ' ' ALA . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.47 0.176 . . . . 0.0 111.442 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.467 ' CG ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -49.39 122.77 6.53 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.008 0.432 . . . . 0.0 111.324 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -150.08 169.63 20.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.914 -179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -137.75 -78.59 0.38 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.54 -26.91 4.61 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 121.285 -0.483 . . . . 0.0 112.206 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.691 HD22 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -70.82 60.72 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.152 0.501 . . . . 0.0 111.824 -179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 22' ' ' ARG . 3.6 p -128.89 -51.39 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.21 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' HG13 ' A' ' 21' ' ' VAL . 4.7 mmt85 -151.46 102.51 2.9 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.951 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 32.0 65.32 0.2 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.927 0.491 . . . . 0.0 112.277 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.05 -155.02 0.55 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.538 ' HE3' ' HB2' ' A' ' 81' ' ' GLU . 0.5 OUTLIER 74.51 72.25 0.1 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.19 0.519 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.7 -48.71 16.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.966 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -39.7 9.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.584 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.75 -43.88 13.32 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.428 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -41.49 48.2 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.023 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.349 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD11 ' CD ' ' A' ' 79' ' ' GLN . 17.3 mt -66.66 -43.45 84.51 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.57 -53.76 44.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.959 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.93 -49.99 79.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.35 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -55.58 -49.76 71.88 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.222 178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.97 -46.27 78.66 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.391 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.62 -51.39 70.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.189 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 73.9 t -57.15 -51.22 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.458 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.6 t -55.4 -49.44 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.316 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -56.38 -43.47 79.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.392 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 11.4 ttt -60.9 -51.05 70.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.77 -53.61 56.29 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.399 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 90.9 t -54.34 -46.99 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.364 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.1 m -58.25 -46.06 86.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.5 ttt -60.77 -50.29 74.04 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.376 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.8 t -59.17 -50.33 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.852 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.12 70.48 4.49 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.1 0.476 . . . . 0.0 110.436 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.9 67.15 0.06 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.927 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.84 101.38 1.62 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.233 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.24 110.8 6.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.731 0.301 . . . . 0.0 111.699 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.9 t -141.93 -69.29 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.016 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -157.56 -64.02 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.1 m -175.7 80.91 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 53' ' ' ILE . 1.3 tt 40.31 50.14 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.745 -0.662 . . . . 0.0 112.313 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.85 55.4 9.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.666 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.44 -28.7 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.918 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 7.2 tp 42.0 71.96 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.477 0.655 . . . . 0.0 111.709 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 0.2 OUTLIER 82.25 141.03 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.385 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.9 p -57.7 -56.82 17.0 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.635 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.7 mt -47.07 -37.95 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.687 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CG ' HG23 ' A' ' 56' ' ' ILE . 6.4 t80 -52.95 -37.99 61.61 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.168 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -46.76 -36.38 7.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.588 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.87 -44.08 24.19 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.143 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.58 -38.54 78.14 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 110.137 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 tp -59.59 -25.34 64.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.73 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.29 -24.65 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.56 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.524 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.0 m -62.4 -65.88 1.88 Allowed Pre-proline 0 N--CA 1.465 0.299 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.314 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 27.9 Cg_endo -61.45 -40.9 44.52 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.087 1.858 . . . . 0.0 111.408 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.9 t-105 -58.98 -50.73 72.99 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.304 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -43.45 93.08 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.655 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 66' ' ' THR . 69.8 t -61.35 -58.94 5.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.804 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -57.07 -46.47 82.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.723 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 t80 -59.31 -53.42 58.47 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.827 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 mp -49.94 -48.08 52.08 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -51.15 67.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.862 178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.97 -49.76 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.042 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.691 HG12 HD22 ' A' ' 20' ' ' LEU . 45.9 t -57.07 -39.67 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.397 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' HD11 ' A' ' 18' ' ' LEU . 38.1 t -63.68 -36.6 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.568 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.433 ' HG3' ' CB ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -82.98 -36.37 25.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.798 179.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 18' ' ' LEU . 9.3 mm100 -45.66 105.13 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.123 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.58 ' HA ' HD22 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -69.84 64.05 0.21 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 47.9 mt-10 -101.5 142.4 32.93 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.621 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 63.0 -67.55 0.08 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.87 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' HD23 ' A' ' 18' ' ' LEU . 8.4 t -122.72 116.75 24.28 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.795 0.331 . . . . 0.0 111.098 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HA ' HD23 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -50.3 121.98 6.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.894 -179.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -137.35 -73.99 0.42 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.195 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 58.01 81.62 0.15 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.801 0.334 . . . . 0.0 111.464 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD22 ' CG ' ' A' ' 16' ' ' MET . 4.0 tp -127.77 62.36 1.4 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.987 0.422 . . . . 0.0 112.031 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' HG3' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -140.44 147.27 39.41 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.302 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 57.4 mtp85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.231 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 120.402 0.144 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.476 ' HB2' ' CD2' ' A' ' 23' ' ' PHE . 1.0 OUTLIER -146.12 153.3 40.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.774 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' VAL . 22.6 ttmt -173.41 111.9 0.2 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.411 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -140.56 -66.45 0.44 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -59.96 85.55 0.02 OUTLIER Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.977 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.643 HD11 ' NH2' ' A' ' 22' ' ' ARG . 0.6 OUTLIER 38.97 59.89 1.54 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 122.757 0.423 . . . . 0.0 111.769 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 38.8 t 88.12 -19.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.674 -0.693 . . . . 0.0 112.732 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.778 ' HD2' HD13 ' A' ' 26' ' ' LEU . 53.0 mtm-85 -85.37 169.34 13.8 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.151 0.5 . . . . 0.0 111.843 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' MET . 5.1 m-85 -74.97 130.67 39.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.0 t 65.88 177.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.372 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.82 63.49 8.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.991 0.424 . . . . 0.0 111.147 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.778 HD13 ' HD2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -48.26 -39.92 23.03 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.668 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 27' ' ' LEU . 1.7 tm? -47.75 -38.41 15.41 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.89 -39.03 11.39 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.892 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.1 tp -46.84 -42.32 17.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.145 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -61.2 -40.01 92.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.578 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 87' ' ' LEU . 4.3 mm? -66.64 -45.49 78.86 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.18 -52.37 61.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 29' ' ' LEU . 82.0 t -58.82 -51.17 75.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.621 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.43 -46.67 76.7 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.33 -47.09 79.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.91 -49.78 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.57 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -56.97 -53.38 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.387 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 41.6 t -56.25 -46.84 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.967 178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -54.55 -56.99 13.26 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.346 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 mtt -51.96 -44.58 64.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.45 -47.78 82.55 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.644 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' VAL . 84.3 t -57.91 -50.57 77.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.717 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.561 HG22 ' HB ' ' A' ' 55' ' ' VAL . 33.9 p -61.97 -49.94 74.09 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.374 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.7 mtp -52.07 -41.98 62.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.786 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.66 -40.16 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.85 63.87 7.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.199 0.523 . . . . 0.0 110.64 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.594 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . 0.6 OUTLIER -101.42 131.61 47.43 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.885 -179.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.78 -144.15 3.85 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.585 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -72.55 95.62 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.666 0.27 . . . . 0.0 110.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.74 179.27 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.73 -49.26 3.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.39 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 75.3 m -53.28 -62.0 1.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.578 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 54' ' ' ASP . 4.0 tt -175.5 -57.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.566 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.594 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -134.47 -62.39 0.74 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.442 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' HB ' HG22 ' A' ' 43' ' ' THR . 3.7 p -62.66 141.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 121.092 0.472 . . . . 0.0 112.129 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -82.97 -67.19 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.237 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -80.28 64.66 5.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 59' ' ' ILE . 81.4 p -65.78 -83.1 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.57 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' N ' ' OG ' ' A' ' 58' ' ' SER . 25.8 mt -51.2 -43.91 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.809 0.337 . . . . 0.0 110.921 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -50.71 -34.63 27.63 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.384 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -45.33 -41.19 8.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.758 -0.201 . . . . 0.0 110.541 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.65 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.95 -43.2 5.34 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.603 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tt -50.95 -48.72 60.91 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 120.731 0.3 . . . . 0.0 110.288 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 tp -62.51 -28.22 69.69 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.779 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.65 HD12 ' HA2' ' A' ' 62' ' ' GLY . 62.2 mt -64.22 -25.06 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.858 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -60.64 -62.97 4.89 Favored Pre-proline 0 N--CA 1.466 0.349 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.303 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.4 Cg_endo -65.26 -42.74 12.62 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.143 1.895 . . . . 0.0 111.733 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -58.35 -46.82 85.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.393 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.56 -49.69 74.3 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.335 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.39 -52.74 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.787 0.327 . . . . 0.0 110.454 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.7 t80 -60.5 -49.42 77.64 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.449 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 76' ' ' VAL . 36.6 t80 -55.11 -46.81 75.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.02 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.72 -52.01 67.52 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.42 -48.05 75.0 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.417 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 71' ' ' TYR . 72.7 t -60.63 -56.75 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 72' ' ' PHE . 71.7 t -51.74 -44.72 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.613 0.244 . . . . 0.0 110.621 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.4 -56.02 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.46 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.426 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.6 tt0 -60.72 -34.23 74.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.922 0.391 . . . . 0.0 110.34 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -57.38 -64.8 0.77 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.976 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 78' ' ' GLU . 0.6 OUTLIER 35.69 38.02 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.96 -76.13 0.19 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.046 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.87 163.7 13.95 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.02 0.438 . . . . 0.0 111.561 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -158.43 58.81 0.45 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.739 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -82.29 -27.99 32.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.342 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.45 -53.0 19.51 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 -67.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.197 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.636 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -166.3 -56.56 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -100.89 150.74 22.53 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 111.107 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.065 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.502 0.191 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.3 152.63 45.36 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.25 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -99.71 -59.18 1.77 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.683 ' HA ' HD22 ' A' ' 27' ' ' LEU . 1.4 tt -76.72 -57.21 3.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.476 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 21' ' ' VAL . . . 75.27 61.92 2.88 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.941 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 58.68 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 111.841 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 19' ' ' GLY . 46.7 t -147.22 -58.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -83.59 -32.63 25.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.658 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.23 154.58 46.93 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.928 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 26' ' ' LEU . 4.3 t -166.82 -173.08 2.28 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.468 ' HA ' ' OE1' ' A' ' 79' ' ' GLN . 0.7 OUTLIER 63.39 -65.43 0.11 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.331 -0.395 . . . . 0.0 112.056 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 24' ' ' SER . 2.5 mm? -65.0 -40.87 95.58 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.983 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD22 ' HA ' ' A' ' 18' ' ' LEU . 3.9 mt -47.69 -33.55 7.02 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -32.93 14.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.326 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -41.61 23.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.809 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.86 -42.61 80.04 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.278 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.17 -40.61 86.63 Favored 'General case' 0 N--CA 1.46 0.058 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.721 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.31 -51.2 74.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.808 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.68 -49.41 82.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.034 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 38' ' ' VAL . 36.7 mt -53.58 -47.54 70.02 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.14 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.79 -47.77 76.51 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.566 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.5 mm -60.76 -49.79 83.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.5 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.37 -51.33 65.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.16 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' O ' HG23 ' A' ' 42' ' ' VAL . 94.9 t -56.85 -47.5 82.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.75 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.9 -49.62 70.8 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.915 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 83.4 mtp -54.34 -51.78 63.65 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.474 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.16 78.86 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.0 t -58.14 -50.7 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.801 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.8 m -60.46 -42.34 96.0 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.097 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 50.2 ttm -67.72 -43.83 79.07 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -78.27 -44.87 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.37 75.36 0.38 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 154.17 43.7 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.42 -65.7 0.02 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.053 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.51 -72.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.649 0.262 . . . . 0.0 111.023 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 m -139.57 127.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.817 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.72 173.71 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.063 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 t 59.66 -157.99 0.32 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.932 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.971 HG21 HD11 ' A' ' 56' ' ' ILE . 17.6 mt -143.55 122.56 7.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.859 0.362 . . . . 0.0 110.917 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -62.07 154.14 27.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.792 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t 67.09 -65.26 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.888 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.971 HD11 HG21 ' A' ' 53' ' ' ILE . 12.5 pt -73.24 62.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -67.07 -47.75 70.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.017 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.6 p -68.51 -57.83 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.784 HD13 HG22 ' A' ' 56' ' ' ILE . 4.2 mp -46.91 -38.08 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.167 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -45.84 -37.9 6.7 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.901 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -46.21 -38.54 8.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.245 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -46.28 -42.86 13.46 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.326 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -42.58 80.52 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.973 0.416 . . . . 0.0 109.938 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.11 -26.84 61.14 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.945 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 98.2 mt -54.43 -31.67 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.308 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.615 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 17.4 m -63.09 -68.21 0.88 Allowed Pre-proline 0 C--O 1.238 0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.556 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.615 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.6 Cg_endo -60.19 -39.22 70.58 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.997 1.798 . . . . 0.0 111.425 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.481 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 38.2 t90 -60.78 -47.04 88.12 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.337 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.01 -45.84 89.69 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.03 -52.69 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.673 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -52.57 65.03 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.743 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -56.38 -54.55 44.24 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.184 179.012 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.422 ' C ' HD23 ' A' ' 73' ' ' LEU . 10.5 tt -49.74 -52.36 32.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.235 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.26 -57.26 13.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -52.2 -41.56 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.389 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.764 HG22 ' HG ' ' A' ' 87' ' ' LEU . 83.4 t -61.95 -47.54 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.66 -39.37 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.571 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -74.53 -44.65 50.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.995 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' A' ' 25' ' ' MET . 0.0 OUTLIER -71.64 81.56 0.84 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.474 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -35.68 112.03 0.15 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -162.87 -68.4 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.434 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 52.64 41.24 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.074 0.464 . . . . 0.0 111.144 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.8 t -127.11 -156.88 0.77 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.356 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.32 55.74 0.7 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.996 0.427 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 -173.96 2.42 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.311 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -70.79 55.48 0.17 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.22 0.533 . . . . 0.0 111.576 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.764 ' HG ' HG22 ' A' ' 76' ' ' VAL . 14.5 tp 172.16 45.01 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.07 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.4 m -77.53 172.97 12.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.862 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.277 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.356 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.381 0.134 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -140.43 -51.77 0.48 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.717 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 2.0 mtpt 74.66 -165.29 0.09 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.837 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.695 HD23 ' HG3' ' A' ' 81' ' ' GLU . 4.9 mp 71.43 -64.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.546 0.338 . . . . 0.0 111.593 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.13 94.52 0.07 OUTLIER Glycine 0 C--N 1.335 0.52 0 O-C-N 123.418 0.448 . . . . 0.0 113.467 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 51.4 83.08 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.4 t -121.02 -74.56 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.327 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.62 -51.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.99 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -115.1 36.78 3.74 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.017 0.437 . . . . 0.0 110.617 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.6 p -127.27 -83.49 0.61 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.054 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.85 60.37 5.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.952 0.406 . . . . 0.0 111.238 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -42.85 90.0 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.901 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 31.5 mt -47.51 -31.4 4.26 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.529 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.1 -44.33 15.54 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.293 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -51.28 -42.24 60.99 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.72 179.091 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.27 75.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.761 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.66 -46.05 70.17 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -50.32 80.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 75.0 t -60.03 -49.36 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 34' ' ' LEU . 12.4 mt -55.49 -46.39 76.92 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.255 179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.71 -48.56 79.24 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.31 -44.52 88.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.06 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.2 t -59.24 -51.9 67.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.826 178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 42' ' ' VAL . 71.3 t -54.51 -48.14 70.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -54.58 -54.53 40.17 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.108 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.7 ttt -54.37 -50.02 68.47 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.467 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -55.38 -48.91 73.58 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.319 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 38' ' ' VAL . 78.9 t -56.81 -49.37 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.096 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.179 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.3 m -56.22 -46.79 79.36 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.667 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.0 ttt -63.51 -46.32 86.6 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.149 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 41' ' ' ALA . 98.2 t -64.67 -48.45 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.5 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.09 58.76 0.7 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.209 0.528 . . . . 0.0 111.234 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.86 149.51 35.91 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.65 -61.22 0.67 Allowed Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.165 -0.541 . . . . 0.0 113.164 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.7 -55.99 1.8 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 50' ' ' VAL . 6.8 p -155.42 68.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.209 0.528 . . . . 0.0 111.61 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.06 -54.58 5.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 56' ' ' ILE . 68.3 m 58.91 65.02 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.939 0.399 . . . . 0.0 111.708 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 53' ' ' ILE . 0.1 OUTLIER -88.64 -33.62 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.506 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -99.87 -74.63 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.286 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 55' ' ' VAL . 3.5 m -76.96 60.48 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.139 0.495 . . . . 0.0 110.915 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 52' ' ' SER . 4.8 tt -76.51 122.89 31.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.265 0.555 . . . . 0.0 111.675 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.664 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 8.0 mtp85 -78.24 68.39 4.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.675 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -53.19 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.97 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -45.13 -40.82 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.339 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -44.7 -37.18 3.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.569 179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -42.98 -46.65 5.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.221 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.62 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -42.56 -46.05 5.66 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.585 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -47.63 67.89 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.8 tp -64.44 -27.39 68.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.62 HD12 ' HA2' ' A' ' 62' ' ' GLY . 58.0 mt -65.22 -21.09 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.9 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.629 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.64 -63.74 3.84 Favored Pre-proline 0 N--CA 1.466 0.329 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 38.1 Cg_endo -64.98 -38.3 29.48 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.016 1.811 . . . . 0.0 110.972 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 65' ' ' ILE . 10.4 t90 -57.24 -48.87 77.73 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.012 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.64 96.31 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.594 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 66' ' ' THR . 54.1 t -59.47 -47.33 91.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-O 120.958 0.408 . . . . 0.0 110.35 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.34 -52.16 55.71 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.1 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.04 -52.46 50.75 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 109.948 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.5 tt -54.89 -48.74 72.62 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.8 m -50.68 -52.08 43.29 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 87' ' ' LEU . 86.2 t -59.08 -49.08 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.822 178.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.24 -46.72 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.56 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 73' ' ' LEU . 70.9 t -57.15 -51.48 68.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.427 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -66.68 -37.78 85.44 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.186 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -71.61 -52.7 16.69 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.026 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp 64.31 -67.96 0.1 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.038 0.535 . . . . 0.0 111.652 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.695 ' HG3' HD23 ' A' ' 18' ' ' LEU . 6.1 mt-10 -133.55 -47.33 0.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.003 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.92 -62.3 0.32 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.241 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.69 -62.61 0.45 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.586 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.9 62.86 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.755 0.312 . . . . 0.0 111.643 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER 46.3 66.2 1.01 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.722 179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 85' ' ' GLN . 7.3 mpt_? 73.56 130.52 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.637 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.465 ' HB3' HG13 ' A' ' 75' ' ' VAL . 1.8 tp -77.95 -38.8 44.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.192 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.9 t -117.89 -167.97 1.43 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.242 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.621 -0.705 . . . . 0.0 111.28 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.2 158.59 22.05 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.731 0.301 . . . . 0.0 111.44 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.34 97.8 1.0 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.055 0.455 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.629 HD23 HG13 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -83.87 68.5 9.99 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.609 -179.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.34 65.25 0.25 Allowed Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.291 -0.481 . . . . 0.0 112.292 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 18' ' ' LEU . 1.8 pp -157.64 -41.1 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.432 0.293 . . . . 0.0 111.413 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.629 HG13 HD23 ' A' ' 18' ' ' LEU . 18.4 m -56.75 141.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.2 mtm180 -71.7 62.35 0.4 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.217 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.26 55.3 0.74 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.002 0.429 . . . . 0.0 110.968 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.75 133.29 8.31 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.385 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 69.98 -60.85 0.47 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.284 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 12.0 mt -47.12 -49.5 21.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.672 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -51.51 -41.69 61.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.13 -32.36 64.17 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.01 -33.74 26.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.75 179.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.65 -40.82 88.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.572 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mp -71.87 -45.58 60.84 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.125 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.7 t -55.61 -53.28 38.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.852 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.93 -47.02 83.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.737 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.0 tp -54.1 -46.73 72.16 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.421 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.45 78.42 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.437 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.4 mt -60.15 -48.51 87.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.326 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.93 -49.85 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 34' ' ' LEU . 68.9 t -59.24 -47.95 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.166 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -46.84 77.05 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.387 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -48.26 75.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.478 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.91 -55.07 34.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.625 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 38' ' ' VAL . 95.1 t -54.23 -45.02 67.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.2 m -58.2 -45.58 87.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.098 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -43.99 97.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.04 -45.03 96.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.84 134.92 43.38 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.13 -59.97 0.5 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.22 -39.11 2.85 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.905 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.92 32.88 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.099 0.476 . . . . 0.0 111.714 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' VAL . 8.4 p -89.28 47.68 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 121.269 0.557 . . . . 0.0 111.191 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -49.6 -37.7 28.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.554 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.4 t -104.75 99.5 9.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.693 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.92 -45.72 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.772 0.32 . . . . 0.0 111.165 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.5 -67.27 0.95 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.486 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.2 t -141.27 132.05 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.805 0.335 . . . . 0.0 110.955 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' ILE . 6.0 tp -60.88 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.041 0.448 . . . . 0.0 112.104 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER 62.63 87.42 0.1 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.501 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -44.37 -59.29 2.48 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.266 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mt -48.83 -45.95 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.284 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.464 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 54.0 t80 -53.07 -36.29 60.5 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.249 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -48.76 -37.04 17.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.61 0.243 . . . . 0.0 110.396 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.04 -35.18 18.07 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.428 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.51 -41.95 81.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.141 0.496 . . . . 0.0 110.125 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' HE3' ' A' ' 68' ' ' TRP . 0.5 OUTLIER -56.64 -23.87 44.4 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.132 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 96.5 mt -52.4 -32.01 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 111.296 0.11 . . . . 0.0 111.296 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.633 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 21.3 m -62.13 -67.39 1.1 Allowed Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.343 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' HD13 ' A' ' 64' ' ' LEU . 26.1 Cg_endo -60.57 -37.86 77.07 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.076 1.85 . . . . 0.0 111.65 178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.703 ' HE3' HD12 ' A' ' 64' ' ' LEU . 1.2 t-105 -62.34 -43.3 99.15 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.542 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.62 73.83 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -58.36 -53.83 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -55.83 -52.53 63.68 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.481 179.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 76' ' ' VAL . 73.2 t80 -54.84 -53.65 52.63 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.941 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -52.61 -49.79 64.37 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.427 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -62.96 1.49 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.819 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -47.98 -53.13 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.316 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 72' ' ' PHE . 54.4 t -51.63 -49.34 34.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.436 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 73' ' ' LEU . 55.6 t -60.54 -51.02 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.586 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.696 ' HA ' HD13 ' A' ' 87' ' ' LEU . 4.0 mt-10 -60.96 -39.07 88.13 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.189 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.421 ' O ' ' HB3' ' A' ' 80' ' ' LEU . 17.5 tt0 -68.69 -19.42 64.38 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.595 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.4 OUTLIER 66.18 97.06 0.05 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.668 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -116.12 -60.49 1.86 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.724 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -81.33 -79.3 0.17 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.7 t -79.65 178.23 8.3 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.21 0.528 . . . . 0.0 111.925 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -98.71 63.17 1.41 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.882 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -66.87 -44.2 81.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.827 0.346 . . . . 0.0 110.068 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 69.29 84.28 0.15 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.684 178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.696 HD13 ' HA ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -124.29 -77.16 0.59 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.279 178.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 54.6 p -109.95 -81.81 0.57 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.959 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.577 0.751 . . . . 0.0 111.367 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 mtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 120.522 0.201 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.521 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 2.4 mpp? -74.35 86.08 1.98 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 16' ' ' MET . 57.2 mttt 81.42 130.24 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.015 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 3.7 mm? -72.67 -51.44 19.43 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.26 -90.52 0.83 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.236 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 tp -103.93 -63.13 1.22 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.758 0.314 . . . . 0.0 111.081 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 t 67.85 40.52 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.941 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -95.18 -42.42 8.58 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.468 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.73 78.6 1.64 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.658 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.9 p 71.0 -176.82 0.2 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.793 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.404 ' HG2' ' CG1' ' A' ' 76' ' ' VAL . 4.1 tpt -76.22 64.71 2.06 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.022 0.439 . . . . 0.0 110.54 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.44 -46.16 56.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.497 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 80' ' ' LEU . 2.8 mm? -46.9 -34.11 5.16 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.82 11.73 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.2 mp -47.5 -39.37 15.93 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.155 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 82' ' ' GLU . . . -57.65 -41.62 81.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.649 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 6.1 mp -68.28 -44.32 75.8 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.252 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 64.8 t -59.47 -51.01 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.566 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.11 -51.75 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.132 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -54.25 -49.13 70.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.126 178.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.48 -50.6 72.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.33 -48.07 80.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.1 t -58.19 -52.69 55.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.341 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.3 t -55.21 -49.32 73.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.53 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -57.79 -55.2 37.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.36 -47.07 69.75 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.78 0.324 . . . . 0.0 110.536 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.3 70.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.66 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.0 -52.46 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.451 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.01 -44.04 87.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.621 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.2 ttt -58.17 -48.69 79.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.231 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.47 -33.96 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.635 0.255 . . . . 0.0 111.149 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 84.48 1.18 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.918 0.389 . . . . 0.0 110.681 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -39.2 116.32 0.58 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.406 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.5 -66.18 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.49 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.62 143.17 50.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.559 0.219 . . . . 0.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 m -52.0 -48.51 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.922 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.15 101.1 0.53 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.924 0.392 . . . . 0.0 111.238 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.31 169.23 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 53' ' ' ILE . 7.0 mt -88.52 1.9 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.757 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 55' ' ' VAL . 2.8 t70 -119.05 169.3 10.04 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -165.16 -47.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.053 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.557 HG23 ' HG2' ' A' ' 57' ' ' ARG . 3.1 tt -160.31 -45.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.672 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.557 ' HG2' HG23 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -147.68 57.37 1.11 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.045 0.45 . . . . 0.0 110.9 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 61' ' ' PHE . 2.7 t -65.3 -50.67 64.8 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mm -43.61 -43.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -47.68 -35.69 9.96 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.771 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -43.84 -42.88 5.93 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.138 179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -41.88 -46.27 4.96 Favored Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.499 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.63 -49.02 63.06 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.672 0.272 . . . . 0.0 110.302 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 2.4 mt -63.1 -26.98 69.08 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 32.9 mt -64.57 -24.85 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.912 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.16 -63.22 4.43 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 35.5 Cg_endo -63.87 -37.29 45.51 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 121.884 1.723 . . . . 0.0 110.895 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.486 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-105 -55.39 -51.93 65.2 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.423 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.74 -49.02 74.67 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.08 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.7 t -55.58 -48.75 77.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-O 120.934 0.397 . . . . 0.0 110.792 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 75' ' ' VAL . 11.4 m-85 -66.52 -48.53 69.46 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.717 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.6 m-85 -56.22 -54.17 48.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.805 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mp -56.07 -50.47 70.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.773 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.7 m -57.2 -48.5 78.63 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.046 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 71' ' ' TYR . 46.5 t -57.29 -49.1 81.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.07 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.083 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 72' ' ' PHE . 67.4 t -56.25 -49.54 75.9 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.7 t -52.65 -38.83 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.871 0.367 . . . . 0.0 110.298 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -92.35 11.01 27.42 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.14 164.93 12.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.201 0.201 . . . . 0.0 110.584 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -113.35 -65.08 1.22 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.586 0.231 . . . . 0.0 111.36 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.89 139.11 47.24 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.138 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HG2' ' HB1' ' A' ' 30' ' ' ALA . 0.0 OUTLIER 55.59 -164.21 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.43 ' HB2' ' HG ' ' A' ' 31' ' ' LEU . 10.1 t -121.15 -40.73 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.004 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -70.04 94.46 0.87 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.452 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 0.6 OUTLIER 75.45 115.95 0.06 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.436 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.23 92.6 0.42 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.327 0.584 . . . . 0.0 111.777 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.46 162.9 40.54 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.874 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t 69.66 172.32 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 111.446 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.335 -179.78 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 82' ' ' GLU . 10.8 tmm? . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 70.02 -58.25 0.54 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.546 0.338 . . . . 0.0 111.718 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -123.55 75.13 1.3 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.143 0.497 . . . . 0.0 110.95 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 ' HB3' ' HG2' ' A' ' 82' ' ' GLU . 6.9 tt -138.59 129.21 26.28 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.32 105.7 0.86 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.242 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 21' ' ' VAL . 3.0 tm? -49.89 -41.63 46.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.809 0.338 . . . . 0.0 110.77 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -120.48 83.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.291 178.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 21' ' ' VAL . 36.7 ttt180 91.84 154.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.983 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -52.31 144.11 13.52 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 78.87 157.99 0.17 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.032 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.403 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 44.6 ttm -74.21 74.58 1.8 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.463 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mp -50.3 -36.17 30.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tp -49.46 -33.98 15.61 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.97 -35.93 2.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tp -48.23 -36.26 13.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.29 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.24 -42.64 91.54 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.683 0.277 . . . . 0.0 110.585 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -47.21 67.47 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.912 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 68.8 t -55.88 -54.37 27.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.405 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 37' ' ' VAL . 53.0 t -55.49 -48.76 76.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -55.42 -49.71 71.67 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.209 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.81 -49.29 73.62 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.29 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 33' ' ' VAL . 48.5 mt -56.04 -49.03 77.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 33' ' ' VAL . 70.9 t -56.45 -47.36 81.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.298 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.08 -50.26 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.279 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -45.9 84.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.484 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 43.1 ttp -61.02 -48.76 80.29 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.316 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.68 -54.31 48.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.378 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' HA ' HG22 ' A' ' 45' ' ' VAL . 46.6 t -53.86 -44.86 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.233 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.551 HG23 ' HA ' ' A' ' 50' ' ' VAL . 36.2 m -59.56 -41.13 89.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.033 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 mtt -69.54 -39.17 77.62 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 42' ' ' VAL . 27.3 m -79.19 -30.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -63.77 127.66 32.34 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 111.16 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -56.24 -35.52 67.48 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.3 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.05 124.11 6.4 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.041 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.73 105.99 0.51 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.676 0.274 . . . . 0.0 111.584 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' HA ' HG23 ' A' ' 43' ' ' THR . 21.4 t 78.56 129.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.689 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.79 59.2 0.86 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.214 0.53 . . . . 0.0 110.791 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.6 p -177.95 43.21 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.95 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 26.5 pt -75.13 -31.09 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.69 -57.19 6.02 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.256 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.4 86.99 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.389 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 56' ' ' ILE . 19.4 tt -81.64 97.07 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.324 0.583 . . . . 0.0 111.049 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 2.7 mmm-85 -135.0 128.71 32.91 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.325 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -56.76 -60.23 3.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.879 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.37 -39.65 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.039 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 19.2 t80 -47.96 -38.16 16.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.094 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -47.73 -35.83 10.43 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.038 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.26 -41.18 11.35 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.234 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.79 -44.81 70.43 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.822 0.344 . . . . 0.0 110.189 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 tp -61.51 -27.65 68.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.776 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER -62.81 -23.02 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.331 179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.669 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.18 -64.88 2.58 Favored Pre-proline 0 N--CA 1.467 0.378 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.8 Cg_endo -64.85 -40.05 23.1 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.892 1.728 . . . . 0.0 111.257 178.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.535 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 6.8 t90 -56.66 -51.11 70.01 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.54 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.08 89.82 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.066 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 66' ' ' THR . 48.9 t -55.43 -52.06 50.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.913 0.387 . . . . 0.0 110.606 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.48 ' O ' HG23 ' A' ' 75' ' ' VAL . 17.0 m-85 -64.62 -51.27 63.52 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.468 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.535 ' HB2' ' O ' ' A' ' 68' ' ' TRP . 0.1 OUTLIER -52.0 -55.11 22.51 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.824 179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.6 mp -54.29 -49.95 68.44 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -53.88 -57.4 11.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.733 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 71' ' ' TYR . 47.8 t -56.31 -45.89 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.471 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 72' ' ' PHE . 41.7 t -57.22 -41.69 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.957 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 73' ' ' LEU . 77.1 t -60.44 -43.08 93.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.027 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -74.03 -40.68 62.71 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.925 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -47.38 107.6 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.71 90.42 2.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.001 0.429 . . . . 0.0 110.997 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -62.22 -179.11 0.2 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.221 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 18' ' ' LEU . 22.3 mt-10 68.27 -57.74 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.198 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.5 p -51.68 135.76 28.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.835 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -72.54 63.57 0.58 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 110.837 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 84' ' ' ARG . 1.8 tt0 75.15 136.13 0.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.931 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 -98.44 -39.0 8.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.758 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 tp -165.51 -53.33 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.673 0.273 . . . . 0.0 111.163 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -157.79 -166.37 1.97 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.17 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.488 ' CG ' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.389 0.138 . . . . 0.0 111.11 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.22 153.71 0.98 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.993 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.54 57.22 0.89 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.385 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HB3' HD21 ' A' ' 20' ' ' LEU . 1.8 mp -94.38 123.26 37.68 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.891 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.07 66.48 0.5 Allowed Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.257 -0.496 . . . . 0.0 113.336 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -157.08 -65.32 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.521 0.201 . . . . 0.0 111.193 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 22' ' ' ARG . 40.7 t -130.68 -72.83 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.148 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HG2' HG12 ' A' ' 21' ' ' VAL . 25.2 ptt180 -175.91 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.35 40.69 1.91 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.04 0.448 . . . . 0.0 110.566 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' CB ' ' HG3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -121.71 175.32 6.31 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.644 -179.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.14 63.25 2.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.408 0.623 . . . . 0.0 111.991 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mp -64.1 -34.43 78.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.292 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 tp -47.46 -36.9 10.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.47 -33.91 10.2 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' A' ' 15' ' ' MET . 0.2 OUTLIER -49.16 -34.94 15.5 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.082 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -57.34 -43.18 83.21 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.744 0.306 . . . . 0.0 110.396 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.4 tp -71.05 -47.15 60.12 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.466 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 36' ' ' ILE . 12.0 t -55.78 -53.27 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.233 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 37' ' ' VAL . 55.5 t -58.76 -50.82 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.15 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 38' ' ' VAL . 1.4 mp -51.7 -48.47 63.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.341 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.56 -52.37 62.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.56 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 32' ' ' VAL . 38.7 mm -57.45 -45.68 85.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.17 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 33' ' ' VAL . 91.3 t -57.49 -44.94 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.113 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.5 t -61.32 -47.63 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.122 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -43.59 87.65 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.443 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 1.1 tpp -65.07 -52.58 54.84 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.236 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.78 68.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 38' ' ' VAL . 53.3 t -54.76 -48.5 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.0 m -56.7 -51.93 66.9 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.851 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.691 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 ttp -55.24 -46.08 76.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.241 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.35 -50.02 78.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.09 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -52.22 63.63 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.36 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -163.39 67.59 0.19 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.016 0.436 . . . . 0.0 110.646 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 44' ' ' MET . . . -82.38 -107.49 0.43 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.375 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 6.8 mt-30 54.56 66.01 1.35 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.414 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 59.4 t 85.11 -41.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.196 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER 66.05 -63.09 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.5 p -168.63 120.81 0.8 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.657 0.265 . . . . 0.0 111.203 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 54' ' ' ASP . 1.6 pp -56.72 -35.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.097 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' HB2' HD12 ' A' ' 53' ' ' ILE . 1.3 t0 -127.04 177.29 6.74 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.013 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.702 HG22 ' HB2' ' A' ' 58' ' ' SER . 13.0 p -71.15 58.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.532 0.682 . . . . 0.0 111.408 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.505 HG23 ' HG3' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -60.37 -35.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.486 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 56' ' ' ILE . 66.0 mtt-85 -97.44 31.32 2.56 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.702 ' HB2' HG22 ' A' ' 55' ' ' VAL . 39.0 t -53.19 -62.86 1.38 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.255 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.4 mt -47.7 -42.79 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.613 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 28.7 t80 -47.61 -40.29 19.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.258 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -46.45 -41.56 14.07 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.902 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.88 -45.15 18.94 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.322 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.9 tp -60.19 -38.56 83.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.776 0.322 . . . . 0.0 110.43 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.549 HD12 ' HA ' ' A' ' 61' ' ' PHE . 2.2 mt -59.6 -23.02 62.62 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.784 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.5 HD13 ' HE3' ' A' ' 68' ' ' TRP . 31.3 mm -56.66 -32.97 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.64 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 6.6 m -61.12 -66.19 1.7 Allowed Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 28.4 Cg_endo -61.8 -38.02 62.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.163 1.909 . . . . 0.0 111.739 179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.5 ' HE3' HD13 ' A' ' 65' ' ' ILE . 12.5 t90 -60.62 -51.72 68.2 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.696 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.73 -47.74 84.47 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.368 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.0 t -56.7 -54.75 25.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.224 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -56.09 -51.1 69.09 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.192 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -51.88 -53.92 35.14 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.171 178.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.89 -52.52 62.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.383 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.48 -46.17 66.44 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 71' ' ' TYR . 79.9 t -58.73 -50.05 80.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.774 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . 78.3 t -51.19 -37.7 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.892 0.377 . . . . 0.0 110.446 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.4 t -69.73 -40.53 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.003 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -85.89 -26.75 25.42 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.618 ' HA ' ' HD2' ' A' ' 86' ' ' ARG . 2.8 pt20 -92.64 -170.89 2.59 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.677 0.275 . . . . 0.0 111.19 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 pp -87.73 174.56 8.33 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 120.888 0.375 . . . . 0.0 110.871 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.04 -69.43 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.518 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' CB ' ' A' ' 24' ' ' SER . 5.0 tt0 -150.44 -49.82 0.13 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 m -75.85 -69.31 0.5 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.094 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.16 113.11 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.975 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -152.32 34.15 0.52 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.429 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD2' ' HA ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -175.17 159.37 2.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.112 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.23 128.13 54.45 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.845 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.2 p -148.2 172.35 14.47 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.31 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.326 0.108 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.45 150.0 49.72 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.691 0.281 . . . . 0.0 111.122 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -74.48 66.08 1.33 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.107 0.479 . . . . 0.0 111.643 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mp -78.65 61.68 3.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.097 0.475 . . . . 0.0 111.06 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.678 ' HA3' HG11 ' A' ' 76' ' ' VAL . . . 71.76 -71.5 0.89 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.55 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 24' ' ' SER . 0.2 OUTLIER -81.29 141.37 34.14 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.636 0.255 . . . . 0.0 110.892 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.64 -32.1 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.537 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.4 mmt85 -107.58 173.1 6.47 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.339 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.81 61.71 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.117 0.484 . . . . 0.0 111.738 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 20' ' ' LEU . 28.3 t -100.63 -160.89 0.83 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.794 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 79' ' ' GLN . 4.5 tpt 54.06 42.4 31.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.851 0.357 . . . . 0.0 111.307 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 pp -44.37 -37.27 3.26 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.072 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.99 -35.63 11.25 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.77 -41.76 15.85 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.583 0.23 . . . . 0.0 111.302 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.16 -41.62 27.36 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.037 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.17 89.71 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.735 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.58 -44.26 67.73 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 61.4 t -58.17 -51.13 74.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.788 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.87 -46.39 96.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.028 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.31 -51.92 60.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.26 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.42 72.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.826 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.9 mt -55.93 -51.34 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.575 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 74.5 t -57.73 -50.27 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.664 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 42' ' ' VAL . 30.0 t -56.17 -49.79 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -58.47 -46.31 86.87 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.583 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 2.0 tpt -59.57 -48.82 80.17 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.132 179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.64 -55.66 32.26 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.545 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 38' ' ' VAL . 98.5 t -52.86 -47.22 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.462 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 51' ' ' GLU . 22.9 m -61.28 -44.93 96.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.718 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -42.79 99.24 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.642 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.72 -26.05 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -84.74 -176.4 6.21 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.956 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -50.18 -45.97 53.88 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.41 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.27 -99.58 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.041 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 68.73 -57.35 0.51 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 111.537 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.603 ' HB ' HG12 ' A' ' 53' ' ' ILE . 0.8 OUTLIER -150.07 117.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.763 0.316 . . . . 0.0 111.292 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HG3' HG21 ' A' ' 43' ' ' THR . 18.0 mp0 -69.91 58.53 0.15 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.457 ' CB ' HG12 ' A' ' 56' ' ' ILE . 1.2 m 59.48 84.71 0.11 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.578 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.603 HG12 ' HB ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -102.65 -75.73 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.1 -45.15 3.64 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.3 t -37.37 -46.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG12 ' CB ' ' A' ' 52' ' ' SER . 1.5 pp -94.48 134.03 33.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.922 0.391 . . . . 0.0 111.146 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -71.58 92.89 1.17 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.62 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.2 p -31.75 -55.54 0.28 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.096 0.558 . . . . 0.0 112.46 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 pt -45.83 -34.42 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -50.52 -29.36 10.39 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.599 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -45.9 -41.35 11.3 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 122.941 0.15 . . . . 0.0 110.836 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.72 -42.44 14.62 Favored Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.388 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -56.61 -42.15 78.28 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.931 0.396 . . . . 0.0 110.206 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 12.1 tp -60.54 -25.29 66.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.927 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -60.9 -25.94 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.316 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 m -61.06 -65.06 2.4 Favored Pre-proline 0 N--CA 1.466 0.338 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 29.2 Cg_endo -62.22 -42.17 30.49 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.162 1.908 . . . . 0.0 111.629 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -58.63 -47.87 82.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.639 179.095 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.21 -50.16 71.36 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.793 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.9 t -56.37 -48.68 79.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.977 0.418 . . . . 0.0 110.394 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.3 m-85 -62.73 -56.01 21.46 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.351 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 76' ' ' VAL . 3.3 m-85 -51.25 -55.36 18.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.959 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -52.41 -47.55 66.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.152 179.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.7 m -58.09 -48.18 80.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.536 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.886 HG12 ' HG3' ' A' ' 79' ' ' GLN . 59.5 t -54.92 -46.48 76.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.815 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.678 HG11 ' HA3' ' A' ' 19' ' ' GLY . 59.7 t -56.3 -43.62 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.487 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 87' ' ' LEU . 52.8 t -59.81 -45.36 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.426 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -89.03 13.02 13.92 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.886 ' HG3' HG12 ' A' ' 75' ' ' VAL . 0.4 OUTLIER -112.57 121.51 45.0 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.863 0.363 . . . . 0.0 110.767 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.479 HD22 ' HG2' ' A' ' 89' ' ' ARG . 2.4 pp -65.99 133.01 49.93 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -116.39 169.27 9.44 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.364 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.69 52.07 1.08 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.987 0.423 . . . . 0.0 111.401 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.434 ' OG ' ' NH1' ' A' ' 84' ' ' ARG . 4.5 t -133.12 -59.09 0.89 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.28 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' NH1' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -165.54 29.11 0.05 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.0 -179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.57 170.52 0.26 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.099 0.476 . . . . 0.0 111.136 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.9 mmm180 -131.24 -103.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.61 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.542 HD12 HG12 ' A' ' 77' ' ' VAL . 1.1 mt -90.89 89.37 7.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.769 0.319 . . . . 0.0 110.681 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.84 -50.16 0.38 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.655 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG2' HD22 ' A' ' 80' ' ' LEU . 3.4 tpt85 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.165 -0.921 . . . . 0.0 111.385 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.47 0.176 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.21 175.7 5.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.205 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.25 138.75 52.57 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.208 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -164.77 162.9 21.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.03 -139.37 2.5 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD22 ' CD ' ' A' ' 81' ' ' GLU . 12.2 tp -71.33 70.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.204 0.526 . . . . 0.0 111.299 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.756 HG11 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -152.11 -173.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.333 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -107.15 -54.69 2.44 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.952 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -131.91 131.37 42.65 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 t 73.06 160.03 0.23 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.227 0.536 . . . . 0.0 112.029 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.8 mtt -82.93 69.2 9.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.851 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.756 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.32 -42.12 98.15 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.682 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.439 HD22 HE22 ' A' ' 79' ' ' GLN . 0.5 OUTLIER -42.36 -39.15 2.07 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.593 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.21 -38.03 17.37 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.909 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tp -47.11 -39.8 14.1 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.609 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -57.5 -41.27 80.43 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.709 0.29 . . . . 0.0 110.724 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.78 -39.94 66.33 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.116 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.62 -49.74 79.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 37' ' ' VAL . 71.6 t -60.94 -50.66 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.12 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -54.48 -45.33 73.18 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.429 179.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.38 -50.41 73.75 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.252 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.8 mt -57.65 -44.24 85.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.94 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 33' ' ' VAL . 71.5 t -59.76 -49.93 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.228 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 34' ' ' LEU . 97.8 t -57.73 -47.95 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.087 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.54 -53.33 58.76 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.799 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.5 mtp -56.84 -41.61 78.2 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.283 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.92 -48.73 79.05 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.794 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.3 t -56.39 -47.28 81.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' OE1' ' A' ' 51' ' ' GLU . 91.0 m -55.79 -51.29 67.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.153 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.9 tpp -59.37 -43.05 92.92 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.676 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 t -62.46 -42.78 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.786 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -58.59 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.152 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 53.36 46.41 26.38 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 116.25 -167.39 12.47 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.501 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.75 -67.93 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.606 0.362 . . . . 0.0 111.665 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.1 t -136.45 100.67 2.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.901 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' OE1' HG23 ' A' ' 43' ' ' THR . 2.3 mt-10 -147.28 -69.55 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.4 p -137.13 79.23 1.74 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.674 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.23 178.51 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.605 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 66.98 -172.6 0.19 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 t -80.06 66.85 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.108 0.48 . . . . 0.0 111.333 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 tp -101.2 -40.05 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.106 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 59.43 79.84 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.75 0.31 . . . . 0.0 111.5 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.2 t -28.39 -49.57 0.07 Allowed 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.7 mm -43.88 -35.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -47.34 -33.99 6.38 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.164 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -45.46 -39.11 6.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.868 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.11 -43.84 18.56 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.27 -0.491 . . . . 0.0 112.25 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mp -56.45 -40.45 74.85 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.129 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -58.19 -27.51 63.94 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.966 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -56.75 -29.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.298 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.574 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 5.3 m -60.99 -66.63 1.43 Allowed Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 31.9 Cg_endo -62.72 -40.66 35.35 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 121.885 1.723 . . . . 0.0 111.514 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 28.1 t-105 -57.55 -52.68 64.41 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.547 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.97 98.63 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.9 -59.25 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 120.658 0.266 . . . . 0.0 110.636 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -58.31 -48.64 79.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.619 ' O ' HG23 ' A' ' 76' ' ' VAL . 8.9 t80 -58.82 -49.42 77.76 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.725 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 tt -53.12 -47.58 68.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.196 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -49.53 76.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.049 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.81 -46.88 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.185 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 72' ' ' PHE . 85.0 t -54.61 -41.33 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.157 178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.62 -43.79 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.487 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -73.45 -37.24 65.89 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.625 -0.262 . . . . 0.0 111.511 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.439 HE22 HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -66.44 70.38 0.07 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.96 0.409 . . . . 0.0 111.13 179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.44 -58.58 7.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' HD22 ' A' ' 20' ' ' LEU . 2.2 tt0 -158.58 88.44 0.92 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.738 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 83' ' ' SER . 29.4 tt0 76.91 159.6 0.21 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.054 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.4 OUTLIER 73.69 144.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 65.5 54.78 1.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.345 0.593 . . . . 0.0 110.277 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -82.67 -35.85 26.47 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.422 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -97.03 -54.78 3.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.32 -69.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.37 -37.51 10.44 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.283 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.433 ' O ' ' HB2' ' A' ' 16' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.313 0.101 . . . . 0.0 111.205 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 69.08 -64.2 0.34 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' HE2' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -112.25 -64.26 1.32 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.596 0.221 . . . . 0.0 111.596 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 69.81 -178.12 0.22 Allowed 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.872 0.368 . . . . 0.0 111.258 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 25' ' ' MET . . . -174.06 59.98 0.13 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.631 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 26' ' ' LEU . 0.2 OUTLIER 83.21 145.75 0.07 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.155 0.582 . . . . 0.0 111.641 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 21' ' ' VAL . 14.5 p -78.95 62.68 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.548 0 CA-C-O 121.377 0.608 . . . . 0.0 111.477 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.21 58.88 1.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 111.031 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 71.88 -64.39 0.39 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.546 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -131.94 -163.58 1.35 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.625 0.25 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.716 ' SD ' HG13 ' A' ' 76' ' ' VAL . 21.1 ttt -66.73 95.07 0.33 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.629 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 20' ' ' LEU . 5.0 tp -49.27 -46.54 46.41 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.647 -0.252 . . . . 0.0 111.278 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 27' ' ' LEU . 3.4 mm? -54.54 -38.25 66.36 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.71 -29.76 54.18 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.713 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -48.98 -34.18 12.5 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.744 -0.207 . . . . 0.0 110.756 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.66 92.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.784 0.326 . . . . 0.0 110.445 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 72' ' ' PHE . 19.8 tp -67.76 -41.58 83.1 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.975 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 36' ' ' ILE . 87.4 t -59.16 -54.51 33.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.921 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -56.63 -51.94 59.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.102 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -53.42 -47.37 69.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.25 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.33 -47.49 85.21 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.391 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 32' ' ' VAL . 22.1 mm -57.02 -49.69 78.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.5 t -55.58 -46.69 79.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.953 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 34' ' ' LEU . 83.8 t -58.1 -51.41 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.538 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -44.85 71.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.0 ttt -65.87 -50.29 65.05 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.642 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.77 -53.81 52.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.776 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 38' ' ' VAL . 97.8 t -56.06 -45.68 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.348 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.815 HG21 ' HA ' ' A' ' 51' ' ' GLU . 80.5 m -59.8 -45.24 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.531 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.5 tpt -58.75 -50.85 72.41 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.229 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.14 -37.56 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 111.234 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.53 77.67 7.32 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.6 t60 77.22 -55.57 0.54 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.38 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 49' ' ' GLN . . . 127.49 -135.52 8.79 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.992 -0.623 . . . . 0.0 113.111 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mp0 68.42 -179.54 0.23 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.666 0.27 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HG3' ' A' ' 51' ' ' GLU . 15.5 m -68.82 -43.59 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.815 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.0 OUTLIER -166.36 -52.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.432 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.5 p -120.09 155.69 32.5 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.337 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.7 tt -110.07 -44.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -169.08 -68.02 0.02 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.631 0.253 . . . . 0.0 111.154 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 m -68.84 62.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.165 0.507 . . . . 0.0 111.49 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.5 tp -122.42 142.78 37.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.235 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.457 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . 38.1 mtp180 -125.88 102.87 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.936 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.8 t -44.49 -48.99 10.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.147 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.86 -37.17 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.672 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . 8.0 t80 -53.41 -33.38 53.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.781 -0.19 . . . . 0.0 110.996 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -49.55 -37.13 25.9 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.631 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -46.98 -41.48 14.06 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 121.247 -0.501 . . . . 0.0 112.373 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.85 -41.45 77.94 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.981 0.42 . . . . 0.0 110.372 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 68' ' ' TRP . 9.8 tp -58.34 -26.35 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.958 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.1 tp -56.62 -29.08 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.458 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.596 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 10.3 m -61.8 -66.48 1.53 Allowed Pre-proline 0 C--O 1.235 0.317 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.45 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 25.9 Cg_endo -60.74 -39.87 59.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.191 1.927 . . . . 0.0 111.733 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.442 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -61.03 -48.84 79.91 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.416 179.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -48.04 81.26 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.665 0.269 . . . . 0.0 110.286 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 66' ' ' THR . 98.0 t -58.35 -54.05 38.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.418 178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -55.92 -49.77 72.55 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.61 179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.58 ' HA ' ' CD2' ' A' ' 31' ' ' LEU . 4.2 m-85 -59.09 -46.35 88.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.983 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.52 -52.65 64.53 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.767 0.318 . . . . 0.0 110.396 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -52.16 66.57 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.529 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 71' ' ' TYR . 68.9 t -54.84 -46.77 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.66 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.716 HG13 ' SD ' ' A' ' 25' ' ' MET . 10.6 t -56.05 -46.38 80.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.528 ' O ' HD23 ' A' ' 80' ' ' LEU . 47.2 t -57.35 -45.3 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.623 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.25 -46.41 33.91 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.537 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.41 ' HG3' HG12 ' A' ' 75' ' ' VAL . 12.2 mm-40 -55.49 -56.86 15.37 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.901 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 77' ' ' VAL . 0.3 OUTLIER 56.8 -158.7 0.25 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.692 0.282 . . . . 0.0 111.22 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.13 53.8 1.28 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.177 0.513 . . . . 0.0 110.657 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.38 -58.73 0.1 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.32 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.1 t -44.65 114.88 0.77 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.142 0.496 . . . . 0.0 111.93 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -84.36 61.49 6.63 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.481 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.79 30.63 6.12 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.317 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.6 ttp-105 -105.23 135.82 45.88 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.203 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -84.88 -45.89 11.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.991 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 m -169.22 -80.12 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.032 -0.985 . . . . 0.0 111.613 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 120.386 0.136 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.452 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -122.32 162.18 21.98 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.672 0.272 . . . . 0.0 111.333 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 16' ' ' MET . 40.7 mttm 73.48 154.34 0.15 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.704 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -146.05 178.94 7.83 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.75 67.62 1.14 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.8 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 70.33 173.83 0.3 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.026 0.441 . . . . 0.0 111.492 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 22' ' ' ARG . 30.0 m -93.93 -39.71 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.516 ' HG2' HG23 ' A' ' 21' ' ' VAL . 39.5 ptt85 -142.15 -48.38 0.36 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -57.93 -24.04 56.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.8 t 68.87 -162.74 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.713 0.292 . . . . 0.0 111.292 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.417 ' CE ' HG13 ' A' ' 76' ' ' VAL . 55.6 mtm -109.01 111.64 23.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 26' ' ' LEU . 2.7 mm? -52.34 -42.97 64.34 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.987 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.53 -44.73 46.7 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.64 -34.17 36.66 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.555 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.3 -37.47 55.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.84 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -36.58 81.31 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.371 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 31' ' ' LEU . 1.9 mm? -68.83 -49.95 54.15 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.1 t -57.28 -49.47 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.971 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.634 ' O ' HG23 ' A' ' 37' ' ' VAL . 40.0 t -57.02 -52.83 50.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.064 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.65 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -53.93 -47.42 71.25 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.6 -51.03 68.54 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.404 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -56.91 -47.06 83.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 33' ' ' VAL . 97.0 t -55.69 -46.73 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.981 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.5 t -58.61 -49.17 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.154 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -56.65 -43.57 80.44 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.322 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.8 mtp -63.62 -50.57 68.82 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.171 178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.15 -50.89 68.15 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.455 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -55.6 -45.53 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.6 m -58.29 -46.63 85.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.945 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.469 ' HA ' ' C ' ' A' ' 48' ' ' GLY . 77.7 mtp -58.87 -51.06 71.65 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.964 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.47 -41.81 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.234 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.49 -50.44 63.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.385 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -135.0 -59.06 0.8 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.709 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.469 ' C ' ' HA ' ' A' ' 44' ' ' MET . . . 170.92 173.62 38.17 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.971 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' CA ' ' HG2' ' A' ' 44' ' ' MET . 0.0 OUTLIER -75.04 69.05 1.91 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.88 0.371 . . . . 0.0 111.468 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 m -139.95 127.82 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.578 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' SER . 8.4 mm-40 -79.04 80.01 5.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.922 0.391 . . . . 0.0 110.702 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 63.6 m 74.98 168.21 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.074 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 53' ' ' ILE . 8.2 tt -128.89 118.53 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.978 0.418 . . . . 0.0 111.613 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 47.32 48.42 16.31 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.463 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 55' ' ' VAL . 4.1 p -160.25 101.17 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.044 0.45 . . . . 0.0 111.491 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 56' ' ' ILE . 9.2 tt -77.12 65.69 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 121.494 0.664 . . . . 0.0 111.415 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -85.12 62.08 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.344 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.5 p -69.51 -69.02 0.37 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.762 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.6 mp -46.55 -38.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.302 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -48.2 -32.41 7.06 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.256 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.445 ' HA ' HD13 ' A' ' 64' ' ' LEU . 2.2 t80 -48.64 -31.92 7.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.255 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' HA2' HD12 ' A' ' 65' ' ' ILE . . . -44.53 -40.78 6.51 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.441 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.48 -44.97 76.99 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.771 0.319 . . . . 0.0 110.315 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 61' ' ' PHE . 3.6 mp -59.22 -25.8 64.32 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.913 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.484 HD12 ' HA2' ' A' ' 62' ' ' GLY . 75.0 mt -60.98 -28.95 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.228 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.641 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 4.7 m -61.79 -62.61 5.52 Favored Pre-proline 0 N--CA 1.468 0.43 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.367 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 30.4 Cg_endo -62.39 -40.07 42.21 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.953 1.769 . . . . 0.0 111.364 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -58.21 -49.78 75.87 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.295 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -64.53 -47.66 78.0 Favored 'General case' 0 CA--C 1.527 0.066 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.86 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 53.7 t -56.51 -49.5 77.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-O 120.777 0.322 . . . . 0.0 110.57 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.8 m-85 -65.21 -55.29 19.37 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.201 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.642 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.0 t80 -49.58 -49.76 45.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.995 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -58.59 -50.15 74.85 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -53.88 -50.67 65.81 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.866 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 71' ' ' TYR . 29.2 t -57.37 -50.24 77.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.81 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 72' ' ' PHE . 60.5 t -50.83 -38.27 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.916 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 73' ' ' LEU . 53.3 t -68.33 -52.67 34.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.652 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -36.73 26.83 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.29 64.06 0.25 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.244 0.545 . . . . 0.0 111.722 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -44.5 6.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.352 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.52 112.97 23.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.809 0.338 . . . . 0.0 111.745 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.44 139.64 52.69 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.001 0.429 . . . . 0.0 111.163 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -172.16 37.83 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.339 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.51 -48.02 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.485 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.78 -56.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.197 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 58.95 -171.66 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.959 0.409 . . . . 0.0 111.594 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.2 173.89 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HG22 ' A' ' 75' ' ' VAL . 3.8 m -101.06 -50.67 3.73 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.943 -179.671 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 31.4 mtp -148.79 -81.49 0.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.134 0.271 . . . . 0.0 111.026 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tttp 75.04 120.02 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.16 -164.08 0.25 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.987 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA2' ' CB ' ' A' ' 28' ' ' ALA . . . -75.06 110.93 3.2 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.324 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.646 HD23 HG12 ' A' ' 21' ' ' VAL . 6.3 tt 75.95 -63.25 0.4 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.573 0.349 . . . . 0.0 110.936 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 20' ' ' LEU . 7.0 p -171.61 -43.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.82 66.15 0.92 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.896 0.379 . . . . 0.0 111.507 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 t80 67.27 69.47 0.38 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.698 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 1.8 m -134.34 -56.57 0.85 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 9.2 mtt -88.29 116.61 26.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.698 0.285 . . . . 0.0 110.75 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -58.37 4.81 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.965 HD22 ' HB3' ' A' ' 79' ' ' GLN . 1.6 mp -38.72 -41.64 0.73 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.534 ' CB ' ' HA2' ' A' ' 19' ' ' GLY . . . -45.8 -42.43 12.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 111.251 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.28 -43.88 53.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.799 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.92 75.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.517 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.544 ' HB3' ' CE2' ' A' ' 72' ' ' PHE . 0.3 OUTLIER -64.54 -47.02 80.34 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 36' ' ' ILE . 41.7 t -61.34 -48.35 89.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.644 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.9 t -56.38 -50.39 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.966 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 38' ' ' VAL . 40.0 mt -57.34 -49.5 75.95 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.066 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.29 74.34 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.574 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 32' ' ' VAL . 35.0 mm -59.19 -50.35 80.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.998 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 33' ' ' VAL . 87.4 t -54.48 -47.04 71.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.228 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 34' ' ' LEU . 96.5 t -55.73 -53.07 41.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.444 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -59.16 -41.35 88.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.671 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.7 ttm -59.67 -51.45 69.76 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.32 59.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.543 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 38' ' ' VAL . 85.8 t -53.85 -46.84 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.568 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.3 m -60.62 -49.16 78.62 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.472 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.5 ttm -59.37 -41.8 90.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.798 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.31 -32.09 55.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.15 157.93 9.65 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.068 0.461 . . . . 0.0 111.508 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -60.63 -31.61 70.8 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.64 -173.78 37.44 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.812 -0.709 . . . . 0.0 113.01 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.81 117.58 0.32 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.78 0.324 . . . . 0.0 111.305 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.26 -70.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.02 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.608 ' HB3' HG13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -111.28 120.88 43.72 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.989 0.423 . . . . 0.0 111.083 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' A' ' 56' ' ' ILE . 4.4 m -167.57 45.97 0.05 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.934 0.397 . . . . 0.0 111.399 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 54' ' ' ASP . 9.3 tt -162.29 -47.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 53' ' ' ILE . 1.5 m-20 -56.73 -70.72 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.7 0.285 . . . . 0.0 111.532 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.25 22.4 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.717 0.294 . . . . 0.0 111.76 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 52' ' ' SER . 24.8 mm -103.84 80.67 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 121.013 0.435 . . . . 0.0 111.253 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.56 35.47 22.65 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.14 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' ILE . 5.7 p -59.19 -64.33 0.98 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.095 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.79 -35.2 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.786 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.438 ' HA ' HD12 ' A' ' 63' ' ' LEU . 30.5 t80 -46.62 -43.78 17.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.574 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -47.59 -41.0 20.72 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.691 179.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.36 -43.47 19.82 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.213 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mt -56.69 -41.3 77.11 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 120.922 0.391 . . . . 0.0 110.093 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 7.1 mp -61.83 -26.61 68.23 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.59 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.82 -25.88 26.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.929 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.02 -65.42 2.14 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 37.6 Cg_endo -64.47 -38.77 31.68 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 121.869 1.713 . . . . 0.0 111.071 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 5.1 m0 -58.45 -47.62 83.41 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.289 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.05 -47.56 82.46 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.343 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 66' ' ' THR . 74.8 t -55.15 -54.47 24.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.193 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.642 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.1 m-85 -59.37 -51.65 69.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.429 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 1.2 m-85 -50.9 -58.04 7.01 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -49.4 57.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.356 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.2 t -56.95 -48.71 77.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 71' ' ' TYR . 50.5 t -60.86 -52.11 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.532 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 72' ' ' PHE . 84.3 t -54.43 -47.65 70.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.143 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 80' ' ' LEU . 33.0 t -59.77 -53.54 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.934 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.05 -40.31 80.61 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.013 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.965 ' HB3' HD22 ' A' ' 27' ' ' LEU . 65.2 mt-30 -58.27 -75.87 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.254 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 77' ' ' VAL . 0.8 OUTLIER 34.26 34.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.684 ' O ' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -139.3 98.02 3.42 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 110.927 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -66.21 69.07 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.568 0.699 . . . . 0.0 110.678 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -78.27 -175.43 4.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.844 -178.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -53.63 8.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.465 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 0.8 OUTLIER -174.73 155.41 2.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.986 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 85' ' ' GLN . 0.2 OUTLIER 33.26 74.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.588 0.555 . . . . 0.0 112.108 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 81' ' ' GLU . 44.2 tp -81.95 -56.65 3.83 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.952 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 t -76.68 153.29 35.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.593 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.098 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.9 tmm? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.216 0.055 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.428 ' HG2' ' HB3' ' A' ' 22' ' ' ARG . 1.3 ttm 72.27 166.6 0.3 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.246 0.342 . . . . 0.0 111.285 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.51 35.51 4.16 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.692 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -102.24 106.06 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.818 0.342 . . . . 0.0 110.859 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.33 -81.3 0.2 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.577 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mp -96.27 -75.91 0.52 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.372 0.138 . . . . 0.0 111.372 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG12 ' HD3' ' A' ' 22' ' ' ARG . 2.8 t -123.65 -53.83 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' HD3' HG12 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -159.81 -57.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.11 -179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -116.5 90.17 3.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.001 0.429 . . . . 0.0 110.288 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m -154.08 169.26 23.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 58.57 45.23 16.52 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 tp -42.81 -38.97 2.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.818 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 HD11 ' N ' ' A' ' 85' ' ' GLN . 5.0 mp -44.34 -39.15 4.39 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.446 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.42 -48.38 26.41 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.36 -39.88 58.02 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.591 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -64.71 -35.95 82.72 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.686 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mp -66.67 -49.24 66.8 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 66.0 t -59.71 -49.88 82.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.809 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 36' ' ' ILE . 33.7 t -56.88 -50.8 74.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.216 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 38' ' ' VAL . 2.7 tp -55.58 -46.79 77.2 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.12 -48.08 76.88 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.007 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.626 HD12 ' HA ' ' A' ' 33' ' ' VAL . 38.2 mt -56.4 -48.49 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.706 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 33' ' ' VAL . 72.8 t -56.6 -47.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.99 178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 34' ' ' LEU . 93.2 t -56.75 -51.88 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.256 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -50.06 73.06 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.868 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 15.0 mtt -52.72 -51.61 59.74 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.015 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -55.7 -44.95 77.87 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.4 t -55.22 -47.73 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.49 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.54 -38.84 91.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.651 0.262 . . . . 0.0 110.991 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.9 ttm -66.94 -49.05 66.7 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.516 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 41' ' ' ALA . 34.1 m -73.54 -41.82 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.734 0.302 . . . . 0.0 111.751 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' O ' HG12 ' A' ' 53' ' ' ILE . 3.5 tt -84.69 78.3 9.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.922 0.391 . . . . 0.0 110.601 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 74.39 78.66 0.12 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.065 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.36 -22.4 58.62 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 113.681 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HB ' ' A' ' 50' ' ' VAL . 2.2 mt-30 -79.17 150.84 31.58 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.058 0.429 . . . . 0.0 110.834 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 49' ' ' GLN . 37.2 t 78.97 138.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -45.23 -40.38 7.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.109 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 p -144.45 46.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.758 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 46' ' ' LEU . 3.4 mp 69.0 -58.67 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.436 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -143.83 -171.33 3.51 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.877 0.37 . . . . 0.0 111.361 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.0 m -70.49 69.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 111.809 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -86.47 150.32 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.261 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' CB ' ' HB2' ' A' ' 60' ' ' PHE . 1.5 mpp_? -90.08 128.74 36.38 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.394 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.9 p -60.64 -65.18 0.73 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.608 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 tt -50.34 -30.09 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.593 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.531 ' HB2' ' CB ' ' A' ' 57' ' ' ARG . 3.1 t80 -48.77 -40.72 29.86 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.955 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -50.62 -35.14 28.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.502 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.776 ' HA2' HD13 ' A' ' 65' ' ' ILE . . . -45.77 -40.28 9.08 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.328 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 1.2 tp -53.83 -44.95 70.7 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.973 0.387 . . . . 0.0 110.084 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -28.03 67.37 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.203 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.776 HD13 ' HA2' ' A' ' 62' ' ' GLY . 1.3 mp -63.57 -27.51 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.012 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.58 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -59.63 -63.83 3.73 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.289 179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 28.5 Cg_endo -61.86 -42.08 33.5 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.046 1.831 . . . . 0.0 111.13 178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 1.1 t-105 -57.36 -42.93 83.0 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.55 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -63.55 -48.96 75.35 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.242 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.2 t -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 110.85 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -65.72 -53.59 38.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -57.15 -45.8 83.29 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.87 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 77' ' ' VAL . 3.3 tt -58.54 -51.29 70.52 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.5 m -55.77 -48.07 75.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.574 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG13 ' HG2' ' A' ' 89' ' ' ARG . 2.2 t -56.44 -48.66 79.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.018 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 72' ' ' PHE . 66.6 t -57.7 -45.19 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.722 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 73' ' ' LEU . 95.1 t -57.1 -43.89 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.492 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -80.18 -39.26 29.6 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.802 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -80.69 66.87 6.37 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.228 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.0 tt -72.22 72.93 0.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.522 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 70.18 -60.0 0.5 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.479 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.63 -61.65 0.46 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.529 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 14.8 t -176.52 -178.85 0.96 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 111.822 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -77.49 75.91 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.721 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.591 ' N ' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 65.29 59.14 0.83 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.247 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' HD3' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -88.43 -59.88 2.11 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.722 -179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD23 ' HD3' ' A' ' 86' ' ' ARG . 4.0 pp -140.87 159.05 43.04 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.498 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.26 -175.85 5.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.623 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG2' HG13 ' A' ' 75' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.16 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.569 0.223 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.8 mmt -75.76 165.45 25.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.166 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 133.02 35.42 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.281 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 HD22 ' SD ' ' A' ' 25' ' ' MET . 0.2 OUTLIER -108.8 -53.06 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.47 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.4 ' HA3' ' C ' ' A' ' 23' ' ' PHE . . . -72.5 104.35 1.5 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.9 tt -41.5 -56.46 2.53 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.7 p -97.0 106.93 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 120.894 0.378 . . . . 0.0 111.661 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 49.25 40.75 18.78 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.291 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 26' ' ' LEU . 98.9 m-85 59.77 35.6 22.11 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.501 ' HB2' HG13 ' A' ' 21' ' ' VAL . 31.4 t -46.89 -64.39 0.79 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.467 ' SD ' HD22 ' A' ' 18' ' ' LEU . 2.1 ttm -59.84 -51.42 69.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.877 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 23' ' ' PHE . 5.4 tt -49.08 -40.61 32.51 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.058 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -44.7 -35.6 2.74 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.298 179.429 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.75 -37.94 31.67 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.445 ' O ' HG23 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -49.38 -40.7 36.87 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.764 178.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.26 84.93 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.387 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.0 mt -64.24 -45.1 89.65 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.2 t -59.46 -46.95 92.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 ' O ' HG23 ' A' ' 37' ' ' VAL . 66.5 t -55.83 -49.83 72.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.741 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 38' ' ' VAL . 3.4 mp -56.92 -46.08 82.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.28 78.64 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.353 -0.385 . . . . 0.0 109.974 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' A' ' 33' ' ' VAL . 30.2 mt -58.73 -46.9 90.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.593 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 33' ' ' VAL . 96.1 t -56.75 -45.19 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.091 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 34' ' ' LEU . 91.7 t -61.1 -51.67 70.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.387 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.89 -47.01 78.17 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.712 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttm -63.11 -51.71 65.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.472 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.65 -50.65 62.79 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.831 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 53.0 t -63.21 -49.35 83.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.772 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.1 m -55.91 -37.36 68.8 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.293 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 43.9 mtp -79.93 -47.94 14.22 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.2 t -64.52 -43.48 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -75.21 -179.25 4.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.848 0.356 . . . . 0.0 110.866 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.73 63.4 1.15 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.942 0.401 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.51 -64.31 2.52 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.536 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 71.89 171.42 0.31 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.125 0.488 . . . . 0.0 111.503 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.5 p -81.12 72.63 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.622 0.725 . . . . 0.0 110.934 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.35 -47.95 1.98 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.768 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 57' ' ' ARG . 10.3 m -50.33 153.96 1.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.807 0.337 . . . . 0.0 111.731 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 79.28 -49.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.009 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -87.36 -49.83 6.97 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.888 0.375 . . . . 0.0 110.241 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -78.24 169.07 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.761 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.11 65.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.109 0.481 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -107.04 -26.18 11.27 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -50.57 -57.5 8.01 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.75 0.309 . . . . 0.0 110.98 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mp -52.28 -37.26 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.861 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.27 -37.91 38.43 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.014 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CE1' HD23 ' A' ' 64' ' ' LEU . 4.7 t80 -49.3 -37.33 23.62 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.771 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.73 -41.39 19.51 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.36 -0.448 . . . . 0.0 112.449 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.72 -38.61 78.72 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 117.118 0.459 . . . . 0.0 110.272 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD23 ' CE1' ' A' ' 61' ' ' PHE . 25.5 tp -59.35 -24.84 63.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.873 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -26.34 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.537 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 m -61.08 -65.91 1.88 Allowed Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 33.7 Cg_endo -62.95 -39.04 43.14 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.075 1.85 . . . . 0.0 111.665 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 75.1 t90 -60.02 -50.0 75.47 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.67 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 73' ' ' LEU . . . -61.51 -46.94 87.86 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.627 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.12 -54.34 33.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 110.415 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.6 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.07 -56.36 23.06 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 179.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.8 t80 -53.8 -50.31 66.39 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.092 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.6 tt -54.23 -48.35 71.19 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.2 t -56.96 -50.73 71.74 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 71' ' ' TYR . 65.9 t -55.02 -41.47 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.094 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.81 HG21 ' HB2' ' A' ' 84' ' ' ARG . 71.4 t -61.43 -50.29 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.752 0.311 . . . . 0.0 110.178 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 73' ' ' LEU . 44.2 t -53.95 -39.98 43.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.931 0.396 . . . . 0.0 110.236 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -78.67 -48.73 14.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.771 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 81' ' ' GLU . 29.2 tt0 -58.09 109.89 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.512 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.9 67.59 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.119 0.485 . . . . 0.0 111.224 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -166.42 -179.8 5.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.588 -179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -73.58 -79.17 0.08 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.839 -0.164 . . . . 0.0 110.609 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.2 t 62.41 -62.17 0.11 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.797 0.332 . . . . 0.0 111.467 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.81 ' HB2' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.04 64.26 1.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 1.2 mp0 74.22 129.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.299 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.9 84.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.302 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.89 84.48 2.21 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.446 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.4 m -108.81 117.14 33.42 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.528 -0.748 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.28 153.07 39.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.943 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.632 ' HA ' HD11 ' A' ' 80' ' ' LEU . 4.4 pttt -164.62 86.64 0.45 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.33 165.75 30.69 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 25' ' ' MET . . . -114.18 -52.45 0.45 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.833 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.486 HD22 HD12 ' A' ' 27' ' ' LEU . 0.6 OUTLIER -112.81 -58.45 2.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.455 0.169 . . . . 0.0 111.264 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.88 -84.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -142.33 51.81 1.46 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 24' ' ' SER . 6.2 p90 -161.27 52.84 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.642 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 23' ' ' PHE . 52.0 m 71.58 175.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.446 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.478 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 2.0 mpp? -96.11 66.08 2.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 111.318 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 ' C ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.81 -26.05 63.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.687 ' N ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -47.8 -37.78 14.36 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.763 0.282 . . . . 0.0 111.763 179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.63 -37.1 26.79 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.69 -38.03 44.59 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.821 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 88' ' ' SER . . . -58.03 -39.18 77.73 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.411 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' HG ' HG21 ' A' ' 75' ' ' VAL . 2.4 tm? -68.38 -44.41 75.19 Favored 'General case' 0 CA--C 1.523 -0.07 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.485 HG13 ' HZ2' ' A' ' 68' ' ' TRP . 96.0 t -56.5 -50.57 72.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.852 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.74 -50.88 72.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.052 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -55.0 -47.8 74.18 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.325 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.26 -51.36 68.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.504 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -58.23 -47.82 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.357 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.3 -52.03 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.719 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 34' ' ' LEU . 98.1 t -59.48 -49.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.64 -45.58 77.6 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.593 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 3.4 ttt -64.52 -52.99 54.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.647 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.01 45.7 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.009 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.8 t -55.15 -45.63 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.138 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 51.1 m -60.36 -43.54 96.42 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.377 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 60.6 mtp -61.31 -45.36 94.78 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.463 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 72.3 t -64.56 -47.69 88.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.285 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 117.51 4.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.382 179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.48 70.32 0.28 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.149 0.499 . . . . 0.0 111.004 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 148.54 123.87 1.35 Allowed Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.172 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.12 152.11 44.37 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.401 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.9 m -68.63 64.37 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.995 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.31 30.92 13.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.637 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.2 p -154.01 99.7 2.28 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.452 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 54' ' ' ASP . 3.7 tp -121.05 -53.71 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' HG23 ' A' ' 53' ' ' ILE . 31.6 m-20 -112.31 29.62 7.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.695 0.283 . . . . 0.0 111.589 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -147.13 133.04 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.789 0.328 . . . . 0.0 111.77 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 50.4 mm -73.08 -50.55 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.095 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 0.8 OUTLIER 50.94 48.52 22.88 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.636 179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 t -44.77 -51.79 9.04 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.316 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.61 -40.45 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.491 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 1.6 t80 -50.64 -38.2 44.82 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -48.92 -33.32 10.6 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.176 179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.25 -39.57 7.17 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.603 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 64.9 tp -56.18 -43.33 78.3 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.852 0.326 . . . . 0.0 110.541 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' PHE . 3.9 mp -52.49 -25.38 10.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.469 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.1 -36.44 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -62.69 -65.2 2.28 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.924 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 19.8 Cg_endo -59.41 -39.02 80.41 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.208 1.938 . . . . 0.0 111.906 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.485 ' HZ2' HG13 ' A' ' 32' ' ' VAL . 1.3 t-105 -63.52 -48.58 76.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.05 83.61 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.399 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -58.63 -55.28 23.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.655 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -56.63 -49.98 73.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.73 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.28 -47.8 80.53 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -62.33 -54.87 34.23 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.054 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -53.24 59.9 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 110.76 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.612 HG21 ' HG ' ' A' ' 31' ' ' LEU . 75.2 t -59.04 -43.96 90.23 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.026 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.26 -44.59 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 73' ' ' LEU . 94.7 t -54.88 -52.41 43.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -44.4 91.62 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.18 178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' HG12 ' A' ' 75' ' ' VAL . 28.8 mt-30 -61.5 -39.15 89.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.096 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.632 HD11 ' HA ' ' A' ' 17' ' ' LYS . 0.7 OUTLIER -52.47 -44.73 65.76 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.321 178.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -79.71 -41.93 25.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.758 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.6 -165.14 0.23 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.634 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 45.54 50.92 10.21 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.2 ttt-85 -116.16 -64.67 1.28 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.21 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -157.36 -79.42 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.069 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 179.65 140.67 0.12 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.028 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.531 HD12 HD23 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -118.13 -41.43 2.87 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.757 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 20.8 t -174.02 -50.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.162 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.162 0 O-C-N 123.849 0.718 . . . . 0.0 111.695 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.312 0.101 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 174.39 137.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.301 0.376 . . . . 0.0 111.061 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HA ' HG13 ' A' ' 77' ' ' VAL . 4.7 mtmt 55.94 79.11 0.17 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.943 0.401 . . . . 0.0 111.6 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.34 -59.93 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.038 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.18 -173.55 22.93 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.39 24.21 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.807 0.337 . . . . 0.0 111.694 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.019 HG21 HD13 ' A' ' 27' ' ' LEU . 24.3 t -125.23 87.9 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 111.1 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 59.94 -149.33 0.44 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.811 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.24 -38.91 6.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.688 0.28 . . . . 0.0 111.55 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -73.86 -13.24 60.89 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 12.5 mmt 54.45 51.33 14.35 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.016 0.436 . . . . 0.0 111.139 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 tp -39.72 -39.26 0.75 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.471 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.019 HD13 HG21 ' A' ' 21' ' ' VAL . 4.0 mp -42.81 -39.47 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -47.46 -34.53 7.43 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.816 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.8 tp -50.86 -38.5 49.69 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.729 0.3 . . . . 0.0 110.623 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 34' ' ' LEU . . . -58.57 -40.32 82.79 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.043 178.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -64.87 -52.35 57.05 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.109 178.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -53.82 -51.84 40.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.103 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 37' ' ' VAL . 54.4 t -59.67 -49.23 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.412 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.843 HD11 ' HG3' ' A' ' 85' ' ' GLN . 3.1 mp -52.74 -47.87 67.12 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.75 -49.39 75.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.519 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 mt -59.97 -46.51 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 33' ' ' VAL . 58.2 t -60.86 -51.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.669 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.17 -48.71 83.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.495 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -55.31 35.79 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.455 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -48.76 64.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.447 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.06 64.69 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.19 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG12 HG21 ' A' ' 50' ' ' VAL . 45.5 t -58.51 -44.87 90.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.928 178.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.797 ' HA ' HG23 ' A' ' 50' ' ' VAL . 22.7 m -56.65 -46.54 80.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.7 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 ttt -64.08 -39.08 93.28 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.1 t -70.38 -43.35 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.366 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.46 160.5 29.46 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.905 0.383 . . . . 0.0 111.266 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -128.74 88.71 2.77 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.668 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.46 79.98 1.24 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.369 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.79 -75.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.139 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG23 ' HA ' ' A' ' 43' ' ' THR . 6.4 m -77.39 62.72 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.881 0.372 . . . . 0.0 111.637 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -157.07 179.22 9.5 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.281 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.3 72.39 0.2 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.218 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.7 tt -160.85 -51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.376 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -74.59 -42.07 59.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 111.065 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -68.22 85.45 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.213 0.53 . . . . 0.0 110.49 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mt -62.19 128.94 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.642 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . 2.7 ttt180 71.99 109.79 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.835 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.2 p -49.3 -52.73 25.82 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.85 -35.61 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.24 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' HB2' ' HB3' ' A' ' 57' ' ' ARG . 11.4 t80 -48.58 -32.84 8.71 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.194 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -42.63 -43.1 3.68 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.188 0.305 . . . . 0.0 110.867 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.479 ' HA2' ' HB ' ' A' ' 65' ' ' ILE . . . -41.22 -40.7 2.62 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.535 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.3 tp -50.49 -52.6 36.91 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -25.06 67.75 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.58 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.479 ' HB ' ' HA2' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -67.35 -22.1 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.33 -61.61 7.3 Favored Pre-proline 0 N--CA 1.467 0.388 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.8 Cg_endo -64.81 -40.91 19.96 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.195 1.93 . . . . 0.0 111.463 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -59.99 -47.42 85.9 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.406 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.26 -51.42 69.64 Favored 'General case' 0 N--CA 1.461 0.092 0 CA-C-O 120.592 0.234 . . . . 0.0 110.447 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.1 t -55.71 -51.47 58.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.456 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.588 ' O ' HG23 ' A' ' 75' ' ' VAL . 0.2 OUTLIER -58.81 -52.87 63.86 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.764 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.512 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t80 -53.85 -46.12 71.14 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.871 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.1 mt -56.91 -54.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.068 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -57.86 10.23 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.119 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.672 HG13 HD23 ' A' ' 87' ' ' LEU . 44.1 t -51.28 -47.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.678 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.89 -45.95 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.591 0.234 . . . . 0.0 111.107 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.527 HG13 ' HA ' ' A' ' 17' ' ' LYS . 23.2 t -60.64 -39.21 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.006 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.2 -38.93 30.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.513 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -54.93 126.43 24.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.997 0.427 . . . . 0.0 110.702 179.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.48 -162.82 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.751 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.632 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.3 tt0 -72.66 61.76 0.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.08 0.466 . . . . 0.0 111.591 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -112.71 -71.22 0.76 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.204 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.55 ' HB2' ' HG ' ' A' ' 27' ' ' LEU . 7.1 t 66.82 -161.67 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' NH1' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 58.82 61.92 2.04 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.684 -179.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.843 ' HG3' HD11 ' A' ' 34' ' ' LEU . 1.9 tt0 65.44 -161.8 0.26 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.662 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.24 174.9 0.26 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.59 0.233 . . . . 0.0 111.342 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.672 HD23 HG13 ' A' ' 75' ' ' VAL . 0.2 OUTLIER 33.95 65.85 0.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.191 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 1.4 t -146.25 94.0 2.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.378 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.543 ' HD3' ' CZ ' ' A' ' 71' ' ' TYR . 17.6 tpp85 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.612 -0.708 . . . . 0.0 111.103 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -130.56 171.92 12.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.784 0.326 . . . . 0.0 111.142 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.68 124.47 42.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.58 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.39 -72.22 0.34 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.82 129.39 2.4 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.688 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.547 ' HG ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER 52.95 -173.48 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG23 ' HG ' ' A' ' 20' ' ' LEU . 97.7 t 71.41 121.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.936 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.12 150.52 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.085 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -49.87 104.05 0.06 Allowed 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -177.64 -61.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.516 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -134.95 115.53 13.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.434 179.448 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 pp -112.02 -34.16 6.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.837 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.52 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -41.91 -42.42 2.75 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.448 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . . . -39.8 -40.47 0.97 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.9 tt -42.86 -40.07 2.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.385 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -59.49 -47.36 85.81 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.261 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -67.5 -47.64 69.41 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.525 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.38 -54.31 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.473 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.9 t -56.26 -54.8 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.825 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -53.54 -51.63 62.28 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.798 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.97 -54.51 45.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.435 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.74 -52.8 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.204 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.1 t -57.27 -56.36 15.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.534 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.48 -50.38 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.068 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.84 -53.71 55.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.172 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.1 mtp -53.62 -53.76 47.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.821 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.57 -53.51 57.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.231 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.8 t -55.32 -56.93 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.372 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 m -58.58 -42.75 88.72 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.238 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 37.2 ttp -62.48 -47.36 84.32 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.575 0.226 . . . . 0.0 111.07 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.85 -39.75 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.564 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 49' ' ' GLN . 2.6 tt -63.67 123.17 18.17 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.075 0.464 . . . . 0.0 111.16 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.88 154.23 42.41 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.792 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.91 -55.89 4.79 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.589 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' HB3' HD21 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -72.83 68.31 0.87 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.693 0.282 . . . . 0.0 111.266 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 50' ' ' VAL . 7.6 p 41.16 71.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.615 0.721 . . . . 0.0 112.414 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 53' ' ' ILE . 1.7 pm0 -69.85 63.53 0.2 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.5 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 55.11 35.45 24.79 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.813 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG23 ' HG2' ' A' ' 51' ' ' GLU . 2.4 pp -94.96 -34.47 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.26 -68.27 0.63 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.949 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.0 m -74.91 64.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 111.262 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 53' ' ' ILE . 3.6 pt -76.55 64.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.457 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HG2' ' HB2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -123.23 60.92 1.05 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.348 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.7 t -52.98 -51.39 61.72 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.591 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 59' ' ' ILE . 0.2 OUTLIER -47.09 -34.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.405 ' N ' HG12 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -51.9 -31.91 30.36 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.569 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.2 t80 -47.43 -36.1 9.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.229 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.41 -40.11 7.93 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.91 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -41.05 72.41 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.899 0.349 . . . . 0.0 111.113 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' HB3' ' CD1' ' A' ' 68' ' ' TRP . 8.6 mt -56.16 -24.69 42.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.464 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -32.78 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.913 -0.13 . . . . 0.0 111.339 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.613 ' HB ' ' CD ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -62.59 -66.59 1.46 Allowed Pre-proline 0 C--O 1.237 0.427 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.709 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.613 ' CD ' ' HB ' ' A' ' 66' ' ' THR . 23.5 Cg_endo -60.02 -39.25 72.1 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.039 1.826 . . . . 0.0 111.31 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' CD1' ' HB3' ' A' ' 64' ' ' LEU . 6.0 m95 -58.5 -56.99 14.98 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.24 178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.81 -52.05 61.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.217 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.74 -59.7 2.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -63.53 -55.58 22.84 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.65 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.642 ' CE2' HG21 ' A' ' 76' ' ' VAL . 5.6 t80 -54.03 -53.01 58.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.347 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 tt -56.94 -56.54 20.37 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.448 0.166 . . . . 0.0 110.865 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.2 m -54.51 -53.2 57.55 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 47.8 t -62.39 -62.14 1.3 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.642 HG21 ' CE2' ' A' ' 72' ' ' PHE . 79.4 t -50.65 -49.23 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.867 -0.151 . . . . 0.0 111.308 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.12 -45.63 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.17 40.24 1.15 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.064 0.459 . . . . 0.0 110.669 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 0.2 OUTLIER -126.96 145.67 50.61 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.294 -179.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.9 tp -97.91 -67.23 0.86 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.788 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 87' ' ' LEU . 1.4 mp0 -102.72 69.14 1.06 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 110.598 179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -58.3 133.26 55.54 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.726 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m 178.13 -42.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.468 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.48 -42.36 0.17 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -142.24 -50.84 0.39 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' HA ' ' CD ' ' A' ' 79' ' ' GLN . 3.9 ptp180 -171.54 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.303 0.482 . . . . 0.0 112.303 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.675 ' HA ' ' HB2' ' A' ' 81' ' ' GLU . 6.3 mp -115.43 156.87 24.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.619 0.247 . . . . 0.0 110.836 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.1 p -54.71 98.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.381 -179.364 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.422 0.153 . . . . 0.0 111.041 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.439 ' O ' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -133.93 172.17 13.17 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.832 0.349 . . . . 0.0 111.515 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 16' ' ' MET . 0.1 OUTLIER -165.21 117.6 1.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.122 -179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.77 137.52 7.7 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.53 51.48 4.58 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.074 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tp 76.39 -156.4 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.543 0.337 . . . . 0.0 111.521 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG12 ' HG3' ' A' ' 22' ' ' ARG . 61.0 t -73.87 -70.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' HG3' HG12 ' A' ' 21' ' ' VAL . 60.6 mtm-85 -150.46 120.35 7.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.165 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 68.57 101.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.027 0.441 . . . . 0.0 111.398 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -169.88 -178.81 3.04 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.618 ' SD ' HG13 ' A' ' 76' ' ' VAL . 3.1 ttt 55.45 57.87 5.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.131 0.491 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.95 -40.09 6.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.175 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -40.72 -44.37 2.17 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.785 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 31' ' ' LEU . . . -47.09 -49.23 22.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.463 0.173 . . . . 0.0 110.93 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.2 mp -51.98 -39.85 60.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.292 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 34' ' ' LEU . . . -66.25 -34.53 78.22 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.655 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 28' ' ' ALA . 2.3 mt -64.78 -48.65 73.73 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 178.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.7 t -64.26 -51.35 69.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.23 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 37' ' ' VAL . 43.6 t -54.68 -50.23 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.442 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 1.1 mm? -59.11 -48.96 79.68 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.41 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.28 -47.96 68.72 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.809 0.338 . . . . 0.0 110.16 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.6 mt -62.09 -48.77 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.347 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 33' ' ' VAL . 93.8 t -53.96 -49.0 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.608 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.5 t -58.09 -53.43 45.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.842 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -56.56 -47.11 80.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.978 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 29.4 mtt -61.89 -48.55 79.99 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.76 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.15 -52.86 63.79 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.609 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.53 -48.15 83.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.417 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.4 m -55.82 -49.62 72.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.29 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.4 ttp -59.67 -48.41 81.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.42 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.76 -41.24 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.141 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -58.7 7.37 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.193 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.69 109.29 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.043 0.449 . . . . 0.0 111.889 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.76 -90.68 0.08 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.053 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -137.8 -64.68 0.54 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.601 0.239 . . . . 0.0 111.043 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -139.76 155.64 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.139 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.34 117.69 5.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.629 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 56' ' ' ILE . 5.4 m -174.8 129.14 0.31 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 111.771 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.408 ' H ' HG13 ' A' ' 53' ' ' ILE . 1.7 pp -97.2 -39.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.75 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -104.77 -71.02 0.75 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.764 0.316 . . . . 0.0 110.791 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 p -121.14 142.69 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.086 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.452 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 3.8 pt -74.92 90.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.165 0.507 . . . . 0.0 110.979 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -147.12 76.85 1.43 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.477 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.3 t -61.87 -50.77 70.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.458 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -49.64 -38.13 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.363 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.65 -40.17 52.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.609 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -44.04 -41.08 5.23 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -46.02 -48.89 14.2 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.191 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.42 -38.83 75.0 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 120.714 0.293 . . . . 0.0 110.283 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tp -62.3 -28.08 69.48 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.493 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 62' ' ' GLY . 1.2 tp -62.57 -22.39 29.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.31 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.294 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.621 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -63.67 -64.93 2.38 Favored Pre-proline 0 C--O 1.239 0.505 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.134 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.621 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 34.6 Cg_endo -63.09 -39.63 38.39 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.035 1.823 . . . . 0.0 111.262 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 68' ' ' TRP . 2.6 t-105 -61.38 -43.7 98.41 Favored 'General case' 0 N--CA 1.457 -0.089 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.11 -45.6 92.77 Favored 'General case' 0 C--O 1.226 -0.177 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.4 t -57.12 -48.13 82.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.952 0.406 . . . . 0.0 110.271 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 26.0 m-85 -63.91 -51.8 62.82 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.885 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.77 -51.11 70.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.127 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.45 -45.79 80.66 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.3 m -58.06 -51.63 68.9 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' TYR . 55.3 t -52.71 -43.77 45.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.139 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.031 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.618 HG13 ' SD ' ' A' ' 25' ' ' MET . 38.5 t -55.47 -48.58 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 178.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 63.2 t -64.81 -38.67 83.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.561 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -70.65 -46.94 62.31 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.021 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -70.35 91.85 0.77 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.994 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tp -50.14 112.39 0.67 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.92 57.95 0.82 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 111.677 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.49 -78.69 0.14 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.265 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -97.66 142.48 29.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.415 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.95 -174.44 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.53 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.16 -169.19 2.98 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.43 117.21 3.13 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.973 0.415 . . . . 0.0 111.354 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.36 45.67 0.88 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.974 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.534 ' OG ' ' HD3' ' A' ' 89' ' ' ARG . 47.9 t -121.21 -54.0 2.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.576 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.534 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.814 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 111.501 0.185 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -119.01 177.1 4.99 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.625 0.25 . . . . 0.0 110.907 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -71.85 -65.98 0.7 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.41 46.9 24.76 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.052 0.453 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.45 44.85 7.71 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 24' ' ' SER . 0.3 OUTLIER -71.84 142.35 49.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.244 0.545 . . . . 0.0 111.898 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.623 HG12 ' HG2' ' A' ' 22' ' ' ARG . 57.2 t -70.69 137.26 24.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.747 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.623 ' HG2' HG12 ' A' ' 21' ' ' VAL . 3.0 mmt180 70.18 79.07 0.19 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.752 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 78.9 m-85 75.6 96.71 0.07 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.278 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 42.4 t -142.9 148.72 37.42 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.544 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.618 ' SD ' ' HA ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER 59.41 49.8 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.019 0.438 . . . . 0.0 111.014 -179.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.01 -40.42 3.04 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.65 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 81' ' ' GLU . 0.4 OUTLIER -47.05 -30.96 2.98 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.183 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CZ ' ' A' ' 72' ' ' PHE . . . -45.66 -38.3 6.62 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 120.812 0.339 . . . . 0.0 111.136 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tp -48.67 -40.61 28.69 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.632 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.33 85.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.45 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 28' ' ' ALA . 29.6 mt -62.93 -44.88 94.88 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.76 -50.79 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.349 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.98 -53.75 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.707 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.56 -46.81 70.4 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HZ2' ' A' ' 68' ' ' TRP . . . -58.27 -51.06 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.635 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.0 mt -57.02 -49.08 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.797 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.2 t -58.94 -55.2 24.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.74 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.21 -50.52 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.645 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -56.35 -58.3 8.59 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.595 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.8 ttm -51.06 -49.99 59.52 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.553 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 45' ' ' VAL . . . -52.16 -51.04 60.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.596 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.56 -52.68 58.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.616 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -55.33 -36.76 66.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 28.4 mtp -73.4 -54.71 7.66 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.444 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 41' ' ' ALA . 35.2 m -61.75 -37.78 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.34 116.24 15.85 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.715 0.293 . . . . 0.0 110.682 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 163.02 29.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.541 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.36 45.39 4.38 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.102 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -177.86 5.13 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.648 0.261 . . . . 0.0 111.224 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' CG2' HD11 ' A' ' 56' ' ' ILE . 22.6 m -77.93 -157.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.74 100.89 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.9 0.381 . . . . 0.0 111.211 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t 72.9 149.16 0.09 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.412 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -76.28 65.3 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.247 0.546 . . . . 0.0 110.886 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -170.08 -172.75 1.39 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.841 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 57' ' ' ARG . 93.7 t -79.48 140.33 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.387 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.424 HD11 ' CG2' ' A' ' 50' ' ' VAL . 32.7 mm -65.54 70.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.334 0.587 . . . . 0.0 111.142 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -175.36 90.41 0.05 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.573 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.8 t -48.82 -51.01 31.78 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.682 0.277 . . . . 0.0 111.215 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.5 tt -52.95 -37.06 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.705 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 17.7 t80 -54.81 -35.54 64.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.495 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -51.69 -34.98 40.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.562 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 65' ' ' ILE . . . -49.25 -31.77 12.87 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.413 178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.48 -44.79 69.25 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mp -61.47 -27.48 68.61 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.726 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 62' ' ' GLY . 59.3 mt -62.8 -23.7 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.178 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HD3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -61.43 -64.1 3.51 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.078 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.636 ' HD3' ' HB ' ' A' ' 66' ' ' THR . 36.2 Cg_endo -63.91 -38.84 36.05 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.994 1.796 . . . . 0.0 111.393 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.424 ' HZ2' ' HB1' ' A' ' 35' ' ' ALA . 0.9 OUTLIER -60.5 -44.92 95.47 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.722 179.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.8 85.39 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 66' ' ' THR . 57.8 t -57.23 -52.51 55.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.295 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.47 -50.19 72.44 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.516 ' CZ ' ' HB1' ' A' ' 28' ' ' ALA . 21.4 t80 -55.43 -47.19 76.35 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.849 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.38 -50.22 74.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.469 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -58.7 -55.6 32.98 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.547 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.37 -50.31 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.515 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG13 ' HG2' ' A' ' 25' ' ' MET . 5.9 t -56.5 -53.15 44.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 t -48.07 -46.03 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.595 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -77.65 -39.33 45.4 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.258 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.524 HE22 HD13 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -53.56 -42.8 67.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.857 -179.325 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.618 ' HA ' ' SD ' ' A' ' 25' ' ' MET . 0.2 OUTLIER 50.17 -96.49 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.127 0.267 . . . . 0.0 110.997 -179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 27' ' ' LEU . 2.5 mt-10 -171.57 40.77 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.202 0.525 . . . . 0.0 110.349 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -86.02 64.45 8.59 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.16 0.505 . . . . 0.0 111.354 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.472 ' O ' HD21 ' A' ' 27' ' ' LEU . 20.9 t 57.36 -153.9 0.36 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.673 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.1 113.82 21.32 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.189 -0.319 . . . . 0.0 110.95 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -42.48 111.89 0.29 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.47 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 -75.81 -21.35 57.42 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.64 77.75 1.12 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.027 0.442 . . . . 0.0 111.209 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.4 p -58.8 -46.7 86.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.702 -179.129 . . . . . . . . 1 1 . 1 stop_ save_